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  In the current study, participants with borderline personality disorder (BPD) displayed 
deficits in neuropsychological functioning when compared with healthy controls.  
Participants with BPD performed worse on all measures of cognitive functioning: 
attention, verbal memory, processing speed and a measure of general neuropsychological 
functioning.  The study found that depression was significantly more prevalent in the 
BPD sample compared with the control sample and that there was a significant inverse 
correlation between level of depression and scores on a general index of 
neuropsychological functioning.  Results from ANCOVA analyses revealed significant 
differences existed in neuropsychological performance on all four measures of cognitive 
functioning between the two groups after controlling for depression.  The role of effort in 
testing with persons with BPD was explored, with results indicating that participants with 
BPD provided good effort.  Lastly, the study’s findings showed that those participants 
with a BPD diagnosis and a neurological disease performed worse on the measure of 
general neuropsychological functioning compared with individuals with BPD who had no 
history of a diagnosed neurological disease.  Results from ANCOVA analyses revealed 
that significant differences in neuropsychological performance on all measures of 
cognitive functioning existed between the two groups after controlling for presence of a 
diagnosed neurological disorder. 
  Implications of the study findings have been presented and discussed.  Also, possible 
confounds to the study’s findings were identified and discussed in the hope that future 
replications of the current study will control for such variables and result in robust 
research findings.  Suggestions for future research in this area have been provided to 
assist in the construction of a more complete neuropsychological profile of BPD. 
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Introduction 
 
Borderline Personality Disorder (BPD) is frequently diagnosed in clinical settings 
and continues to be one of the most researched personality disorders in terms of its 
phenomenology, biological markers, treatment response, family history, and outcome 
(Kavoussi, Coccaro, Klar, Bernstein, & Siever, 1990).  BPD tends to be a chronic and 
debilitating syndrome, and is considered a complex disorder largely due to the multiple 
variations in presentation.  There are nine criteria for BPD according to the American 
Psychiatric Association’s (APA) Diagnostic and Statistical Manual, 4th Edition, Text 
Revision (DSM-IV-TR, American Psychiatric Association, 2000), but only five of these 
criteria need to be met to receive a diagnosis.  Therefore, the numerous combinations of 
symptoms that are possible to satisfy diagnostic criteria for a BPD diagnosis allows for 
varied presentations of the disorder. 
In addition to the multitude of ways the disorder can present itself, BPD is further  
complicated by the high degree of co-occurrence with other disorders, such as substance 
abuse disorders (Casillas & Clark, 2002; Grilo et al., 1997; Joyce et al., 2003; Ross, 
Dermatis, Levounis, & Galanter, 2003), depression and other mood disturbances 
(Comtois, Cowley, Dunner, & Roy-Byrne, 1999; Joyce et al., 2003), social phobia  
(Comtois et al., 2003), and posttraumatic stress disorder (Comtois et al., 2003; 
McGlashan et al., 2000; Zlotnick, Franklin, & Zimmerman, 2002).  Because BPD rarely 
presents in “pure” form, but instead presents with co-occurring Axis I or Axis II 
psychopathology, conducting research with individuals diagnosed only with BPD is 
extremely difficult (Donegan et al., 2003).  The high degree of complexity associated 
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with BPD underscores the need for additional research in this area to help improve 
understanding of the etiology, phenomenology and effective treatments of BPD. 
A wide body of  neuropsychological research provides empirical evidence to support the 
idea that individuals with BPD suffer from various cognitive impairments (e.g., Bazanis 
et al., 2002; Beblo, Saavedra, Mensebach, & Driessen, 2005; Carpenter, Gold, & Fenton, 
1993; Dinn et al., 2004; Judd & Ruff, 1993; O’Leary, Brouwers, Gardner, & Cowdry 
1991; Ruocco, 2005; Stevens, Burkhardt, Hautizinger, Schwarz, & Unckel, 2004; 
Swirsky-Sacchetti et al., 1993).  However, the extent to which cognitive impairments are 
the result of psychological distress versus physiological abnormalities remains uncertain. 
Sprock, Rader, Kendall, and Yoder (2000) have suggested that the emotional and 
behavioral dysregulation commonly experienced by individuals with BPD are due to 
neurological dysfunction.  For example, problems with attention, memory, processing 
complex information and impulsivity are all difficulties displayed by individuals with 
BPD and it is likely these deficits lead to psychological distress in the form of disrupted 
interpersonal relationships (Sprock et al., 2000).  Neuropsychological studies have shown 
performance deficits for individuals with BPD, relative to controls, suggestive of 
temporal and/or frontal lobe dysfunction (Sprock et al., 2000; Swirsky-Sacchetti et al., 
1993).  Travers and King (2005) have hypothesized that the cognitive deficits found in 
persons with BPD may be secondary to such brain insults as trauma, encephalitis, or 
epilepsy.  Examining the extent to which neuropsychological deficits in persons with 
BPD can be attributed to brain dysfunction remains an important research question. 
Other physiological research investigating the neuroanatomical aspect of BPD 
suggest abnormalities in the amygdala (Donegan et al., 2003) which is an important 
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structure for emotion regulation, and malfunction of the medial prefrontal cortex which is 
associated with poor inhibition of the amygdala (Bremner et al., 2004).  As a result of 
such findings, these deficits have been hypothesized to be contributing factors to the 
development and presentation of the disorder.  While physiological testing and 
neuropsychological testing provide evidence that perhaps a subset of individuals with 
BPD have cerebral dysfunction that may predispose persons to BPD pathology, overall 
research in this area is limited with variable and assorted findings.  Researchers have yet 
to define a specific neurological profile to fit BPD. 
What follows is a review of various aspects of neuropsychological functioning in 
persons with BPD.  The author will begin with an overview of BPD diagnostic features 
organized around the construct of dysregulation.  Etiological theories for the development 
of the disorder will also be provided.  Next, the paper will review the literature related to 
different areas of neuropsychological functioning in persons with BPD.  Explanations for 
the inconsistent neuropsychological findings within the literature will be explored and the 
validity of assessment data and neuropsychological tests will be addressed.  Finally, the 
direction, methodology, and results of the current study will be presented and discussed. 
Diagnostic Features of Borderline Personality Disorder 
 A hallmark feature of BPD is dysregulation in a number of areas of functioning.  
Criteria for BPD in the DSM-IV-TR (APA, 2000) are associated with patterns of 
behavioral, emotional, and cognitive instability and dysregulation.  Behavioral 
dysregulation may manifest for individuals with BPD through a variety of interpersonal 
problems.  These difficulties may take the form of intense, conflict-ridden relationships 
with deep feelings that are not shared by the other person in the relationship.  Sometimes 
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individuals with BPD share intimate details with others they don’t know well, demand a 
great deal of time from the other person, and idealize others within the first or second 
meeting.  This pattern of behavior is reflective of one BPD criterion, namely frantic 
efforts to avoid real or imagined abandonment (APA, 2000).  Relationship boundaries 
can be violated and challenged by individuals with BPD.  The DSM-IV-TR (APA, 2000) 
states that although individuals with BPD display short tempers, with outbursts of anger 
within relationships, they continue to remain in relationships because they fear 
abandonment.  Regardless of the validity of this fear of abandonment, persons with BPD 
may take drastic measures to avoid being left and experiencing the potential associated 
feeling of being a “bad” person. 
 Impulsivity is another example of behavioral dysregulation that is a prominent 
characteristic of BPD.  Impulsivity can manifest in gambling, reckless driving, 
promiscuity, substance abuse, and reckless spending of money (APA, 2000).  While such 
behaviors are damaging, a more dangerous display of impulsivity by BPD sufferers is 
recurrent self-mutilating or self-harming behaviors.  Frequently, fear of separation serves 
as the impetus for suicide attempts.  Actual suicide attempts and self-injurious acts, such 
as self-mutilation and self-inflicted burns, with little or no intent to cause death are 
defined as parasuicidal behaviors (Kreitman, 1977).  These behaviors frequently occur 
during moments of disassociation.  Such maladaptive behaviors may serve to reaffirm the 
individual’s capacity to feel, or to dispel notions of being an “evil” person. 
 Emotional dysregulation affects individuals with BPD in the form of intense 
mood swings in and out of very depressed, anxious, and irritable states that can last a few 
days or more (APA, 2000).  They live in a world that appears always to be in conflict 
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with their emotions.  Some persons with BPD express anger in the form of violent or 
physically aggressive behaviors.  Anxiety, irritability, and dysphoria are also among the 
mood states that persons with BPD experience with great intensity. However, these 
extreme episodes typically only last a few hours, and on rare occasions persist for more 
than a few days (APA, 2000).  Interruptions to these episodes are characterized by 
displays of anger, panic, or despair without the reprieve from such feelings as 
gratification or contentment.  It is common for stress to incite these mood episodes, 
particularly stress in the interpersonal facets of the sufferer’s life. 
 A chronic feeling of emptiness is another example of how people with BPD 
experience emotional dysregulation.  This can lead them to engage in the habitual pattern 
of thrill seeking behaviors and dangerously impulsive decision-making (APA, 2000).  
Along with the feelings of emptiness, individuals with BPD commonly convey 
inappropriate anger and struggle to manage their expressions of sarcasm, resentment, or 
derision.  These episodes are oftentimes connected with the sufferer perceiving a 
caregiver as being neglectful.  These expressions of anger may result in the individual 
feeling guilty or embarrassed, strengthening maladaptive thoughts that they are inherently 
bad persons. 
 Cognitive dysregulation as a domain of BPD includes depersonalization, 
dissociative symptoms or paranoid ideation.  These forms of thought dysregulation 
sometimes appear during periods of extreme stress and dissipate once the stress is 
ameliorated.  Some persons with BPD have radical changes in beliefs, values, and career 
choices.  These changes also involve the individual’s sexual identity and the type of 
friends they choose.  Frequently, people with BPD have a feeling that they do not exist at 
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all.  In contrast, they can alter their relationship role from a dependent, clinging 
individual to a zealous advocate out to aid those in need.  Another area of impairment 
under the cognitive dysregulation rubric includes cognitive distortions which are 
commonly part of the cluster of displayed symptoms.  Examples of these cognitive 
distortions include odd experiences, superstitious beliefs, and magical thinking 
(Gunderson & Zanarini, 1987). 
Prevalence 
 BPD is estimated to be present in roughly 2% of the general population, 
approximately 10% of individuals in outpatient mental health centers and about 20% of 
psychiatric inpatients (APA, 2000).  Of individuals with a personality disorder, 30% to 
60% are diagnosed with BPD, according to the APA (2000).  An estimated 75% of 
people diagnosed with BPD are females (APA, 2000). 
Etiology of BPD 
Object Relations Theory 
 Several theories of etiology attempt to explicate the complexities of BPD.  One 
prominent theory that proposes a disturbed caregiver-child relationship as a pathogenesis 
of BPD is Object Relations Theory (Westen & Gabbard, 1999).  This theory represents a 
major development in psychodynamic theory within the past 30 years by providing an 
etiological explanation for BPD.  The term “object relations” has several meanings, yet, 
most broadly, the term refers to enduring patterns of interpersonal functioning in intimate 
relationships along with the cognitive and affective processes mediating those patterns 
(Westen & Gabbard, 1999).  Object Relations Theory emphasizes the effects that 
deprivation of healthy human contact has during infancy and early childhood, the 
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importance of self-representations and representations of others (called “object 
representations”) as factors that influence interpersonal functioning, and the basic need 
for human connectedness that begins in infancy. 
 Under healthy developmental conditions, it is theorized that the caregiver allows 
the child to explore and separate in an effort to prompt the child to synthesize the 
different “good” and “bad” selves into one whole.  By providing this experience for the 
child, “object constancy” is created.  If the caregiver prevents the child from separating, 
the “pleasure ego” does not convert into the “healthy” or “reality ego” (Gibson, 1990). 
 Although the child’s desire to separate from the caregiver is a healthy biological 
drive, the caregiver might interpret such behavior as a personal threat (Gibson, 1990).  
The caregiver may not be able to tolerate separation or abandonment and communicate to 
the child that he or she must remain attached to the caregiver or die (Bersin, 1994).  The 
caregiver may respond by withdrawing affection and thereby creating a feeling of 
abandonment and anxiety in the child.  This response establishes a pattern of dependence 
in the child.  Because the child never learns to assimilate or integrate the bad object and 
the good object, he or she develops a dichotomous thinking pattern as a defense against 
reality.  Under these circumstances, the child’s representations of self and object can 
become polarized, that is, all good or all bad.  This form of dysfunctional development is 
labeled splitting, and “from a psychodynamic point of view is a product of the 
irresolvable conflict between intense negative and positive emotions” (Linehan, 1993, p. 
35).  The cognitive preconditions for splitting are thought to establish themselves 
between 12 and 18 months of infancy (Gergely, 1992). 
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 Object Relations Theory posits that once the child moves into adolescence, the 
healthy developmental process requires transference of satisfied libido needs by the 
parent to fulfilling of such needs by a mate that will eventually lead to assuming the 
independence necessary in adulthood (Gibson, 1990).  Adolescents sometimes struggle 
with feelings of growing autonomy that can be equated with abandonment and depression 
and that conflict with the desire for feelings of closeness from his or her parents.  In a 
failed effort to protect against depression and anxiety that result from these feelings of 
dissonance, adolescents may employ defense mechanisms such as denial and projection, 
as well as adopting polarized thinking methods.  Consequently, he or she may resort to 
behaviors that are characteristic of individuals with BPD including affective instability as 
a result of discernible reactive mood and an unstable sense of self-image or sense of self 
(APA, 2000). 
 The preceding description establishes an etiological basis of BPD due to a 
caregiver’s overinvolvement with the child to fulfill his or her own needs.  There is also a 
second theoretical explanation that exists for the development of BPD.  Several 
psychodynamic theorists (e.g., Adler & Buie, 1979; Kohut, 1971; Winnicott, 1991) assert 
that a mother or other caregiver serves as an external validator and regulator of a young 
child’s needs and impulses.  If a child has a caregiver that models a stable, nurturing 
environment, then the child is able to develop internal monitoring and satisfaction of 
impulses and an internal sense of worth.  However, if the caregiver fails to provide a 
validating, nurturing and reinforcing environment, the result can be an undeveloped sense 
of self worth that typifies the individual with BPD.  Consequently, the individual 
continually seeks involvement in relationships in order to feel validated, but maintains a 
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confused state regarding his or her own identity, and resorts to scanning the environment 
for cues on how to act and what to think and feel (Linehan, 1993).  Therefore, within the 
psychodynamic theory of Object Relations a potential second pathogenic element of a 
mother’s interaction with her child (in addition to overinvolvement) is the lack of 
appropriate responsiveness to the child’s impulses and needs (Bezirganian, Cohen, & 
Brook, 1993).  Such inappropriate responsiveness may be conceptualized as a caregiver’s 
inconsistent parenting of the child.  
 Psychodynamic theories (e.g., Adler & Buie, 1979; Masterson, 1978) converge on 
the assumption that significant deficits exist for individuals with BPD in the area of 
interpersonal relationships, particularly in regard to separation-individuation.  The 
individual with BPD experiences feelings of emptiness, anxiety, isolation, and a loss of 
sense of self as a result of an inability to internalize primary mother-child caring.  
Empirical results from a study conducted by Bezirganian and colleagues (1993) showed 
“the combined effect of maternal inconsistency and maternal overinvolvement accounted 
for the effect of poor maternal ego integration on the development of Borderline 
Personality Disorder in the child” (p. 1841).  Such findings suggest that it is the pattern of 
caregiver-child interaction as an environmental factor that may be responsible in 
transmitting the disorder from one generation to the next. 
 More contemporary attachment theorists have advanced etiological explanations 
for BPD beyond that of Object Relations.  Kernberg (1984) has postulated that 
disruptions in childhood attachments contribute to the development of BPD.  As a result 
neuropsychological problems develop that are associated with difficulties in social 
interactions and ineffectiveness in coping with stress caused by abusive environments, 
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disruptive parenting, developmental deficits, and maladaptive coping techniques that 
contribute to one’s pathology. 
 Also, Gronstein (1990) asserted that the neurobiological impairment seen in 
persons with BPD can be traced back to a preverbal developmental period where 
disruptive parenting results in a lack of secure attachment and bonding for the child.  The 
theory supposes that a mother experiencing stress and pathology, including the borderline 
trait of emotion regulation difficulty, will engage in a pattern of interaction characterized 
by affective and self-regulatory limitations with her child by pulling away from her 
distressed child.  This emotional withdrawal by the mother is experienced with great 
intensity by the child.  Consequently, the child has a sense of being bonded to a 
nonnurturing family environment and forms an unstable sense of self.  In more extreme 
conditions involving caretaker neglect and abuse, research indicates that children exposed 
to parental maltreatment, child physical and sexual abuse being the most dramatic 
example, exhibit core features associated with a disorganized style of attachment 
(Barnett, Ganiban, & Cicchetti, 1999; Carlson, 1998; Lyons-Ruth & Jacobvitz, 1999). 
 Children with a disorganized attachment style do not form an adequate bond with 
their caregivers, do not acquire the skills from their caregivers to help them modulate 
affective experiences, and develop a lifelong experience of heightened vulnerability to 
shame and inability to regulate their emotional experiences.  According to Berntson, 
Cacioppo and Quiqley (1991), over time these types of experiences are imprinted onto 
the child’s limbic system and interfere with child’s ability for autonomic control.  
Neuroscience research supports the idea that the childhood experiences of learning to 
regulate emotions and successful navigate fearful experiences are necessary for 
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development of brain structures that help regulate anxiety and develop organized 
responses in frightening situations (Siegel, 2001). 
Biosocial Theory 
 Another etiological theory, the biosocial theory proposed by Linehan (1993), 
posits that BPD is a result of both biological irregularities and dysfunctional 
environments, and in a synergistic fashion ultimately results in a dysfunction in the 
emotion regulation system.  Similar to the psychodynamic view discussed earlier that 
views the mother as an external validator for the child, the biosocial perspective 
postulates that invalidating environments prevent a child from learning how to label and 
regulate arousal, tolerate emotional distress, and learn when to believe in his or her own 
emotional responses to events as valid interpretations of events (Linehan, 1993). 
 Within the biosocial model, individuals with BPD are seen as influenced during 
adulthood by their childhood invalidating environment, and consequently they invalidate 
their own emotional experiences, look to others for cues regarding correct reflections of 
reality, and have a tendency to oversimplify problems (Linehan, 1993).  Because these 
individuals oversimplify their problems, they typically set unrealistic goals, have 
difficulty using reward rather than punishment for small accomplishments, and engage in 
self-hate when failing to achieve their goals.  Individuals with BPD have this shame 
response engrained in them by their invalidating environment that censures them from 
expressing emotional vulnerability. 
 The learning conditions that interact with the biological predispositions are 
characterized, according to Linehan (1993), by an invalidating environment that includes 
rejection, minimizing, and punishing internal experiences thereby thwarting development 
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of effective emotion regulation.  Biological underpinnings for the biosocial theory of 
BPD are unclear, but are believed to include disruptions in the limbic system, the brain 
system responsible for emotion regulation and attention control (Linehan, 1993).  The 
emotion regulation system is complex, making it difficult to identify confidently a 
common variable associated with it as the cause for BPD.  Biological causes could 
potentially include genetic heritability, with studies finding that first-degree relatives of 
persons with BPD have higher prevalence rates affective disorders (Akiskal, 1981, 
Andrulonis et al., 1981), harmful intrauterine factors that later influence behavioral 
patterns in individuals like fetal alcohol syndrome and its sequelae of hyperactivity, 
impulsiveness, distractibility, and irritability (Abel, 1981, 1982), or early childhood 
environmental invalidating events, abuse or trauma that affect the brain and nervous 
system development.  Biological predispositions are reinforced through learning and 
thought to contribute to the development of BPD (Linehan, 1993).  More specifically, 
biological irregularities in the limbic system interfere with effective regulation of affect, 
creating high sensitivity to emotional situations with a delayed return to base line for 
individuals with BPD.   
 Beck and Freemen (1990) provide a similar etiological explanation for 
maladaptive cognitive processes that develop early as a child and manifest as distorted 
cognitions such as “The world is a dangerous and hostile place” or “I am worthless and 
vulnerable.”  These distortions influence the individual’s perception of the world, 
themselves, the future, as well as behavioral and emotional responses. 
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Diathesis-Stress Model 
 Another etiological theory is the Diathesis-Stress Model that states environmental 
risks interact with genetic vulnerabilities, including neurobiological and 
neuropsychological vulnerabilities, to contribute to the clinical syndrome of BPD.  
Diatheses have been identified and include neurobiological markers such as deficits in 
frontal lobe functioning that manifest in neuropsychological difficulties including 
impulsivity, cognitive inflexibility, and perseveration (Judd & Ruff, 1993; O’Leary et al., 
1991; Swirsky-Sacchetti et al., 1993; van Reekum, Conway, Gansler, White, & Bachman, 
1993; van Reekum et al., 1996).  Stressors established as common features associated 
with BPD that also potentially contribute to the development of the disorder include a 
history of psychological trauma, emotional neglect, physical and/or sexual abuse during 
childhood and adolescence, as well as witnessing violence, with trauma being related to 
psychophysiological and neuropsychological changes.  (Goldman, D’Angelo, DeMaso, & 
Mezzacappa, 1992; Guzder, Paris, Zelkowitz, & Feldman, 1999; Guzder, Paris, 
Zelkowitz, & Marchessault, 1996; Yen et al., 2002). 
 Using a Diathesis-Stress Model, Beblo et al., (2005) have proposed the existence 
of an unspecific genetic disposition of individuals with BPD that includes cerebral lesions 
and/or inherent personality traits (e.g., impulsivity).  As a result of this genetic 
disposition, the coping abilities of children may be compromised, leading to an increased 
likelihood of learned negative responses within their disrupted social environment.  
Additionally, this genetic disposition interacting with previously mentioned common 
environmental stressors could contribute further to the development of BPD.  Therefore, 
Beblo et al., (2005) propose that in addition to recurring traumatic experiences in 
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childhood and adolescence as a risk factor, a genetic disposition along with certain 
liabilities in personality may further increase the chances of developing BPD. 
Neurobiological Theory 
 Abnormalities in an individual’s biology provide yet another etiological theory for 
the development of BPD.  The notion of an organic subtype of BPD, as defined by 
neurological deficits, began with a series of prevalence studies in the early 1980’s that 
indicated up to 81% of individuals with BPD had a history some type of neurological 
insult (Andrulonis, Glueck, Stroebel, & Vogel., 1982; van Reekum et al., 1993).  The first 
to note the possible existence of an organic subtype of BPD, Andrulonis and colleagues 
(1982) identified a pattern in the developmental history of a higher prevalence of 
seizures, learning disabilities, head trauma, and attention deficit disorder with or without 
hyperactivity, and acquired brain injuries compared with psychiatric controls.  In an 
attempt to replicate these findings Andrulonis (1990) found that the developmental 
factors were present in 50% of male BPD subjects, but only 20% of the female subjects 
presented with such histories.  As a result, females with BPD were hypothesized to 
display a constellation of symptoms that placed them on the affective disorders spectrum, 
while males with BPD were conceptualized as existing on a spectrum of organic brain 
dysfunction that included episodic dyscontrol syndrome and adult minimal brain 
dysfunction.  van Reekum and colleagues (1993) also found a positive correlation 
between the severity of brain disturbance and severity of behavior disturbance. 
 Travers and King (2005) investigated the degree to which cognitive deficits 
observed in persons with BPD can be attributed to the result of organic insult, either 
developmental or acquired.  Findings from a study by Travers and King (2005) provided 
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partial support for their hypothesis that cognitive deficits in BPD are largely the 
consequence of organic insult.  Subjects with both BPD and a history of organic insult 
were significantly more impaired on measures of attention compared with subjects with 
only a BPD diagnosis (Travers & King, 2005). 
 Schore (1994) has suggested that the emotional dysregulation experience of rage 
that is characteristic of BPD is the result of an inability of the orbitofrontal system to 
modulate the excitatory ventral tegmental limbic circuit, while the depressive states 
associated with feelings of abandonment are due to an inability to regulate lateral 
tegmental circuit inhibition.  As a result of an underdeveloped orbitofrontal system, 
individuals with BPD cannot access symbolic representations that allow for important 
self-soothing, reparative functions encoded in evocative memory.  In addition, their 
autonomic nervous system responsible for emotional regulation and mediating emotional 
responses becomes impaired. 
 The amygdala has been identified as a brain structure associated with 
physiological and behavioral reactions to objects and situations that have particular 
biological significance, including painful stimuli.  While the amygdala is activated in the 
presence of emotionally relevant stimuli, the hippocampus is associated with the process 
of consolidation of information in memory.  These two structures have been the primary 
focus of several neuroimaging studies that have attempted to explicate the 
neurobiological features associated with BPD (e.g., Driessen et al., 2004; Lucas, Gardner, 
Cowdry, Pickar, 1989; Schulz, 1983; Snyder & Pitts, 1984). 
 It has been proposed that the amygdala is the brain structure responsible for 
detecting and responding first to new stimuli in the environment, particularly those 
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stimuli that are potentially dangerous (LeDoux, 1992).  Physiological studies reveal a 
sensory/processing loop where the amygdala connects to the sensory thalamus, which 
connects to the sensory cortex and then back to the amygdala (LeDoux, 1995).  In this 
way, the amygdala serves a critical function in response to urgent situations that allow for 
rapid activation of emotions and interpretation of feedback from the cortex following the 
initial alarm (LeDoux, 1995, 1996).  While the amygdala appears to be active particularly 
during periods of stress or threat, the hippocampal functioning seems to be somewhat 
impaired when exposed to the elevated levels of cortisol commonly produced in 
threatening situations (Nadel & Jacobs, 1998). 
 Neuroimaging studies evaluating the volumes of brain structures revealed 8% 
smaller amygdala and 16% smaller hippocampi in subjects with BPD compared to 
control subjects (Driessen et al., 2004).  Findings from animal research support the idea 
of a correlation between stressful conditions and structural abnormalities in the 
hippocampus and subsequently memory functioning (Bremmer, 1999; Uno, Tarara, Else, 
Suleman, & Sapolsky, 1989).  Neuroimaging research with human subjects has 
demonstrated smaller hippocampal volumes in persons suffering from PTSD (Bremmer 
et al., 1995) and in female survivors of sexual and physical abuse in childhood (Stein, 
Koverola, Hanna, & Torchia, 1997).  Such findings are informative and particularly 
relevant because of the high prevalence of PTSD and trauma history in persons with BPD 
(McGlashan et al., 2000; Sar et al., 2003; Zlotnick et al., 2002). 
 Despite these neuroimaging findings, the association of reduced hippocampus and 
amygdala volume and human traumatic experiences remains unclear.  For example, in a 
study by Driessen and colleagues (2004), the correlations between the reduced structural 
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volumes and trauma existed only with regard to the entire sample but were not present 
when the BPD and healthy samples were analyzed separately.  Other researchers have 
found the reduced volumes of the hippocampus varied considerably from left to right 
hippocampus (Gurvits et al., 1996).  Also, smaller volumes of the amygdala appear in 
some studies (e.g., Bremmer, 1999) while other studies found increased amygdala 
volumes (e.g., Gurvits et al., 1996). 
 Overall, the research evidence that does demonstrate the presence of reduced 
brain volumes in structures like the hippocampus and amygdala supports the hypothesis 
that there exists a subtype of BPD that is organic in nature.  However, because 
individuals with the disorder commonly present with complicated histories of abuse and 
comorbid PTSD diagnosis, it is difficult to determine if BPD symptoms like emotional 
dysregulation have an organic etiology or if the symptoms are the result of exposure to 
certain environmental factors that manifest in the type of psychological distress displayed 
by persons with BPD. 
Neuropsychology of BPD 
 Several characteristics associated with BPD contain pathological features with 
cognitive components including odd reasoning, poor concept formation, dichotomous 
thinking, projection and splitting, selective memory for past experiences, difficulty 
differentiating current experiences from past expectations, and associating anxiety with 
thought processes instead of ameliorating it through action (Kernberg, 1975; Knight, 
1953; O’Leary & Cowdry, 1994; Stone, 1980).  From a clinical perspective, these client 
characteristics manifest through missed appointments, misperceiving situations, 
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explosive responses to innocuous events, poor insight into consequences of one’s actions, 
slow progress in therapy, and general difficulty learning from past experiences. 
 There are several possible explanations for why these psychological cognitive 
components have not been empirically studied until recently.  One reason may be related 
to the psychodynamic conceptualization of these deficits.  That is, splitting, memory 
lapses, misperceptions are conceptualized as defense mechanisms that protect the 
individual from experiencing painful emotions, memories, or conflicts.  Also, in an effort 
to distinguish BPD from schizotypal personality disorder, the cognitive style features 
associated with BPD such as poor insight and cognitive distortions have been 
deemphasized (Kroll, 1988). 
 Another reason noted by O’Leary (2000) that these characteristics of BPD have 
historically not been the focus of neuropsychological studies is because of the often held 
belief that persons with BPD present as “normal” on structured psychological tests such 
as the Wechsler Adult Intelligence Scale-III (WAIS-III; Wechsler, 1997a).  Much of the 
literature concerned with psychological test performance of individuals with BPD is 
characterized by the statement “intact WAIS, disturbed Rorschach” meaning the within 
normal limits profile of structured psychological tests like the WAIS contrasts with 
“psychotic” thinking on unstructured projective tests like the Rorschach (Berg, 1983; 
Carr, Goldstein, Hunt, & Kernberg, 1979; Rapaport, Gill, & Schafer, 1968; Singer, 
1977).  Clinical impressions corroborate research findings in the sense that the BPD 
population demonstrates a normal distribution of intelligence with many functioning well 
in structured work settings (O’Leary, 2000). 
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Neuropsychological Literature on BPD 
 Empirical evidence indicates that individuals with BPD have deficits in several 
areas of neurocognitive functioning (Swirsky-Sacchetti et al., 1993) suggestive of a 
possible underlying brain pathology.  However, the research in this area is limited with 
variable and assorted findings that preclude a clear characterization of the neurocognitive 
features associated with BPD.  Early neurobehavioral studies that seemed to identify a 
relationship between acquired or developmental brain dysfunction and borderline 
pathology failed to provide a consistent picture of neuropsychological deficits 
(Andrulonis, 1990; Andrulonis et al., 1982; Andrulonis et al., 1981; van Reekum et al., 
1993; van Reekum et al., 1996).  More recent neuropsychological investigations have 
used improved methodology and more comprehensive test batteries to identify specific 
neurocognitive impairments among persons with BPD (see Ruocco, 2005 for a review). 
 Although a wide body of literature supports the notion of neurocognitive deficits 
in this population, other studies have not found any significant differences in cognitive 
functioning between persons with BPD and healthy controls.  While the relationship 
between neurocognition and borderline pathology remains unclear, the most consistent 
significant findings appear to be in the areas of attention, verbal memory, visual memory, 
processing speed, and visuospatial perception.  Following is a review of the existing 
literature on neuropsychological testing involving subjects with BPD with particular 
emphasis on those areas of cognitive functioning that have revealed the most compelling 
findings. 
Neuropsychological Correlates   
  
20 
 
Attention 
 Travers and King (2005) used the Digit Span subtest and the Digit Symbol subtest 
from the WAIS- R (Wechsler, 1981) and the Visual Memory Span subtest from the 
Wechsler Memory Scale-Revised (WMS-R; Wechsler, 1987) to measure attention.  The 
Digit Span subtest contains a forward and backward trial, each consisting of seven pairs 
of random-ordered digit sequences that the examiner reads aloud and requires the 
participant to repeat the sequence either forward or backward.  For the Digit Symbol 
subtest, participants are timed and asked to view a list of nonsense symbols paired with 
numbers and use the list as a key to fill in the correct corresponding symbol that is 
missing below a series of numbers that follow.  Besides being a test of attention, visual 
motor coordination, and perceptual organization, it is the one subtest from the WAIS-R 
(Wechsler, 1981) that is considered the most sensitive to brain damage (Lezak, 
Howieson, Loring, Hannany, & Fischer, 2004).  The Visual Memory Span subtest is a 
non-verbal analog of Digit Span and requires participants to reproduce forward and 
backward a pattern of tapping sequences using a set of randomly-ordered blocks 
beginning with 2 and going up to 8 blocks. 
 Travers and King (2005) compared two samples of individuals with BPD, one 
group without any documented history of organic brain injury and a second group with 
evidence of past significant head injury/encephalitis or epilepsy, and/or a current or past 
documented history of learning disability/ADHD.  The results indicated that the BPD 
group with a history of organic brain injury displayed a significant deficit in attention 
relative to the BPD group without any brain injury.  Travers and King (2005) suggest that 
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the attention impairments experienced by persons with BPD may be partly attributable to 
organic factors. 
 O’Leary et al. (1991) also found significant attention impairments in the group of 
BPD individuals compared with healthy controls as measured by the Digit Span subtest 
and the Digit Symbol subtest from the WAIS-R (Wechsler, 1981).   Similarly, Judd and 
Ruff (1993) found significant differences in performance on the Digit Symbol subtest in a 
BPD sample compared with controls.  Posner et al. (2002) used the Attentional Network 
Test (ANT), a reaction-time task that measures the efficiency of several aspects of 
attention (Fan, McCandliss, Sommer, Raz, & Posner, 2002) with a group of individuals 
with BPD and a control group.  The ANT requires participants to press certain keys 
depending upon the type of stimuli that are presented on a computer monitor.  The 
researchers found that there appears to be a specific attentional deficit in individuals with 
BPD concerned with conflict resolution or the ability to identify incongruent stimuli 
during the task. 
 Monarch, Saykin, and Flashman (2004) evaluated attention in persons with BPD 
using several measures including a Continuous Performance Test (CPT), Trail-Making 
Test A and B (Reitan, 1958), and the Digit Symbol and the Digit Span subtests from the 
WAIS-R (Wechsler, 1981).  CPTs actually contain a group of attention measures that 
typically present stimuli briefly and provide reaction times as well as accuracy data.  The 
Trail-Making Test A and B contains two parts.  First, it requires individuals to draw lines 
to connect consecutively numbered circles on one work sheet (Trail A) and then connect 
the same number of consecutively numbered and lettered circles on a second work sheet 
(Trail B).  Results from Monarch et al. (2004) showed that relative to comparison groups, 
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individuals with BPD demonstrated a significant impairment in attention as indicated by 
all measures of attention used in the study.  Monarch and colleagues (2004) concluded 
that “it appears that attention skills in inpatients with BPD are severely compromised” (p. 
77).  The authors added that it is critical to adequately asses for attentional problems 
because such deficits may directly and indirectly affect other areas of functioning by, for 
example, interfering with a person’s ability to organize his or her test-taking behaviors, 
solve problems, and encode and retrieve new information.  
 However, not all research findings support the idea of persons with BPD suffering 
from attention deficits.  For example, Lenzenweger, Clarkin, Fertuck, and Kernberg 
(2004) used another type of CPT, the Continuous Performance Test-Identical Pairs 
Version (CPT-IP; Cornblatt, Risch, Faris, Friedman, & Frienmeyer-Kimling, 1988), to 
assess for sustained attention in a sample of persons with BPD.  The authors found no 
difference in attention ability between individuals with BPD and controls as measured by 
the CPT-IP.  Additionally, Swirsky-Sacchetti et al. (1993) found no significant 
differences between individuals with BPD and controls using two attention measures: the 
Symbol-Digit Modalities Test (Smith, 1968), a test similar to the Digit Symbol subtest 
from the WAIS-R (Wechsler, 1987) and the Trail-Making Test A and B (Reitan, 1958). 
Verbal Memory 
 The WMS-III (Wechsler, 1997b) contains several subtests that are frequently used 
in neuropsychological assessments to assess verbal memory ability.  For example, the 
Paired Associates subtest requires subjects to recall immediately and at delay lists of 
words read to them by the examiner.  The more complex Logical Memory subtest asks 
subjects to recall immediately and again after a 30-minute delay, details of two stories 
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that were read aloud to them by the examiner.  O’Leary et al. (1991) did not find any 
deficits in verbal memory using the Paired Associates subtest for the BPD group, but 
results did reveal they scored significantly lower at immediate and delay recall relative to 
the comparison group on the Logical Memory subtest.  In an effort to further examine the 
nature of memory impairment, O’Leary et al. (1991) provided the BPD subjects with 
cues about the story (e.g., “Do you remember where the robbery took place?”).  
Interestingly, cueing allowed the individuals with BPD to remember additional 
information, eliminating the significant difference in performance between the two 
groups.  The authors proposed that the improvement in performance on this task after 
cueing suggests that the deficits in memory exhibited by the BPD group may be the 
product of difficulty retrieving learned material and not a problem with the original 
encoding process. 
 Similar to findings by O’Leary and colleagues (1991), Dinn et al. (2004) found 
BPD subjects obtained significantly lower scores on the Logical Memory subtest 
compared with controls, but did not find a significant difference in scores between groups 
on the Associate Learning subtest.  Judd and Ruff (1993) also found significant 
performance differences between the BPD group and controls on the delayed recall 
portion of the Logical Memory subtest.  Score differences between groups on the 
immediate recall of the first Logical Memory story approached significance. 
 Swirsky-Sacchetti et al. (1993) conducted research to asses for evidence of 
impaired neuropsychological functioning in BPD and also to determine if there is any 
pattern of deficits.  Results showed that, overall, the BPD group performed more poorly 
than controls across the entire battery of tests, including memory test performance.  The 
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results showed a trend of BPD subjects to be more likely to perform more poorly than 
controls on a verbal-learning task when emotional interference was involved.  However, 
the authors failed to find a significant difference in verbal memory using scores from the 
Logical Memory subtest.  Carpenter et al. (1993) found BPD subjects performed worse 
than controls on the Logical Memory subtest compared to controls but this difference was 
not statistically significant. 
 Sprock et al. (2000) conducted a study examining memory in a sample of 
individuals with BPD, a sample of depressed individuals, and a nonpsychiatric control 
group.  The authors used the Logical Memory, Figural Memory, and the Digit Span 
subtests from the WMS-R (Wechsler, 1987).  The Figural Memory subtest is actually a 
visual memory test that presents subjects with designs for 10 seconds and then asks them 
to reproduce what they remember of each design.   Results showed no significant 
differences between the BPD group, the group of depressed individuals and the control 
group on any of the WMS-R subtests. 
 In an attempt to explore Swirsky-Sancchetti et al.’s (1993) findings of an apparent 
trend for individuals with BPD to be more susceptible to emotional interference than 
controls on verbal-learning tasks, Sprock et al. (2000) included a story recall task 
(immediate and 15-minute delay) to assess memory for complex verbal material and the 
influence of emotional themes on recall.  The story about a woman consisted of 10 
negative, 10 positive and 10 neutral components.  A verbal recall task consisting of two 
word lists was also completed by subjects at immediate recall and after a 1-minute period 
of neutral or emotional interference.  Results revealed a significant difference in scores 
between the BPD group and the control group for neutral words on the delayed story 
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recall task, but the use of emotional interference on the verbal recall task did not affect 
performance of the BPD group or the other groups. 
 Kurtz and Morey (1999) studied memory functions with emotional words among 
a group of individuals with a co-occurring diagnosis of major depressive disorder (MDD) 
with BPD, a group of individuals with MDD without BPD, and a control group.  The 
researchers used four lists of words: three lists containing words with strong emotional 
valences, and one list containing neutral words.  Participants were instructed to judge 
each word using the descriptors “like” or “dislike.”  A free recall trial took place 5 
minutes after the judgment task and a recognition trial took place 50 minutes following 
the judgment task.  Results revealed that MDD participants with BPD performed 
significantly worse on the recall and recognition tasks relative to controls.  While the 
MDD participants with BPD scored lower on these tasks compared with MDD without 
BPD, these differences were not significant.  Both controls and participants with MDD 
and BPD recalled significantly more positive words than negative words.  Participants 
with MDD without BPD recalled more positive words than negative words, but this 
difference was not statistically significant.  Performance in the recognition task mirrored 
that of the recall data: control participants discriminated best across all word valences, 
and MDD participants with BPD scored the lowest of the three groups on the recognition 
task for all word valences. 
 Kurtz and Morey (1999)  state that their data support the hypothesis that relative 
to controls, individuals with BPD displayed difficulties with verbal memory functions in 
both recall and recognition.  These data corroborate a growing body of research findings 
that indicate memory disturbances in persons with BPD. The authors note that the study 
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findings suggest that the presence of BPD in depressed individuals may account for a 
portion of the memory deficits often attributed to depression.  The authors note that 
although their data support the idea of greater specificity of memory deficits in 
individuals with MDD and BPD compared with persons diagnosed only with depression, 
the results are inconclusive regarding several possible causal relationships between BPD 
and memory deficits (see Garber & Hollon, 1991).  That is, the observed memory 
dysfunction in the BPD group may be due to an additive affect of BPD and depression. 
 Renneberg et al. (2005) conducted a study that looked at the ability of a group of 
participants with BPD, a group of participants with depression, and a control group to 
retrieve autobiographical memories, or memories that relate to one’s personal life.  The 
autobiographical memory test (AMT) is comprised of five positive words, five negative 
words, and five neutral words.  Words were presented to participants one at a time and 
then asked “What event does this word remind you of?”  Participants’ response times for 
each cue word were recorded.  A memory was classified as specific if it referred to an 
occasion that did not span more than one day.  The authors hypothesized that BPD 
participants would have more overgeneralized memories with more omissions and they 
would show similar retrieval as depressed persons for negatively valenced memories. 
 Study results from Renneberg et al. (2005) show that participants with depression, 
but not those with BPD, showed significant impairment in terms of number of specific 
retrieved memories compared to the control group.  However, both depressed participants 
and BPD participants retrieved memories that were more negative compared with control 
participants’ retrieved memories.  BPD participants did not differ significantly in reaction 
time from the responses of the control participants.  Renneberg and colleagues (2005) 
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propose that their findings suggest that individuals with BPD have easy and quick access 
to their autobiographical memories with negative emotional valence that may also be 
specific.  The authors suggest that this fast and easy access to negative memories may 
contribute to an inability to adaptively cope with emotional turmoil. 
 In addition to the findings of Renneberg et al. (2005), Kurtz and Morey (1999) 
and Sprock et al. (2000), research has demonstrated that subjects with depression report 
more severe cognitive and emotional symptoms than did subjects who were not depressed 
(Gfeller, Chibnall, & Duckro, 1994).  Subjects with depression also suffer from impaired 
immediate recall of new information and amount of acquisition, and when depression and 
anxiety presented together subjects not only displayed deficits in immediate recall and 
amount of acquisition, but also demonstrated deficits in retrieval of new information 
(Kizilbash, Vanderploeg, & Curtiss, 2002).  These findings are particularly relevant when 
conducting research with a BPD sample because of the high prevalence of depression co-
occurring with BPD (Comtois et al., 1999; Joyce et al., 2003). 
 The findings from Renneberg et al. (2005) are in contrast with Jones et al. (1999) 
who compared responses in an AMT by a sample of BPD individuals to those of controls.  
Jones et al. (1999) found that individuals with BPD recalled more overgeneralized 
memories and had more omissions (retrieval time that exceeded the allotted time limit) 
compared with controls.  While these data suggest deficits in retrieval of specific 
autobiographical memories in BPD persons, Renneberg et al. (2005) and others (Arntz, 
Meeren, & Wessel, 2002; Kremers, Spinhoven, & vander Does, 2004) have not found 
evidence of overgeneralized retrieval in BPD persons indicating inconsistent findings in 
this area of memory functioning with this population. 
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Visual Memory 
 Several neuropsychological studies provide evidence for visual memory 
dysfunction in persons with BPD.  The congruent findings across several comprehensive 
studies in the domain of visual memory offer the most compelling evidence to support the 
hypothesis of cognitive deficits in individuals with BPD.  While it can be difficult to 
distinguish whether a certain test is measuring visual perception or visual memory, the 
Rey-Osterrieth Complex Figure Test (CFT) has been identified as being capable of 
measuring both domains of functioning (Corwin & Bylsma, 1993; Osterrieth, 1944).  The 
CFT presents participants with a visual complex geometric drawing and then asks them 
to first copy the figure and then draw it from memory immediately and after a delay. 
 O’Leary et al. (1991) asked a sample of individuals with BPD to complete the 
CFT and found that the copy score of BPD participants was nearly identical to that of 
controls; however, the BPD participants’ scores were significantly lower than control 
scores at 5 minute recall and at a 45 minute delayed recall.  The authors assert that these 
findings suggest intact visuosperceptual and visuomotor skills but impaired complex 
visual memory.  Additional support for deficits in this area comes from Carpenter et al. 
(1993) who found BPD subjects scored significantly lower compared with controls on the 
CFT.  Judd and Ruff (1993) also found the BPD group performed significantly worse 
than control on the recall portion of the CFT.  Additionally, Judd and Ruff (1993) 
analyzed the CFT copy score and discovered that 92% (n=23) of normals had perfect or 
near perfect scores compared with 20% (n=5) of the individuals with BPD.  The results 
show that the subjects with BPD were unable to copy the figure accurately, and they 
produced either distorted drawings or drawings with missing parts. 
Neuropsychological Correlates   
  
29 
 
 Impaired performance on the CFT in a sample of persons with BPD was also 
found in a study conducted by Swirsky-Sacchetti et al. (1993), corroborating the findings 
by other researchers regarding visual memory deficits with this population.  Swirsky-
Sacchetti et al. (1993) used an older version of the Visual Reproduction subtest, the 
Figural Memory subtest from the WMS-R (Wechsler, 1987), to assess the ability to 
reproduce from memory designs that were presented for 10 seconds.  The reproduction 
ability was tested immediately and following a 30 minute delay.  Results show the BPD 
group produced significantly lower scores compared with controls at immediate and 
delayed recall.  The authors propose that their data indicate visual memory deficits in 
participants with BPD which is consistent with their clinical reports of BPD patients who 
have difficulty with visual recall in daily living and in treatment.   
 Dinn et al. (2004) compared a sample of BPD participants with a sample of 
nonclinical controls.  The authors used the CFT and required participants to copy the 
figure immediately and also at a 1 minute delay.  Results show that the BPD participants 
obtained significantly lower scores on copy organization, copy accuracy, and recall 
accuracy of the CFT.  Inspection of the drawings revealed that they were poorly 
organized and often displayed gross distortions of the geometric figure. 
 Not all findings concerning deficits in visual memory ability in BPD participants 
are as convincing or consistent.  Sprock et al. (2000) included the CFT in their battery 
and although they found the BPD group scored lower than controls for the copy task, 
immediate recall, and at delayed recall, these differences in scores were not statistically 
significant.  Using the WMS-R Visual Reproduction subtest (Wechsler, 1987), Carpenter 
et al. (1993) found individuals with BPD scored significantly lower than controls 
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indicating deficits in visual memory; however, these findings were not replicated in 
O’Leary et al.’s (1991) study.  O’Leary et al. (2000) noted that contrasting findings often  
exist when comparing findings from complex memory tasks (e.g., the CFT) with results 
from simpler visual memory tasks like the WMS-R Visual Reproduction subtest 
(Wechsler, 1987). 
Visual Perception 
 Research investigating visual perception impairment in persons with BPD appears 
to offer consistent neuropsychological findings.  As with other domains, the tests used to 
assess for visual perception vary from study to study.  O’Leary et al. (2000) noted that the 
strongest findings were found when using the Digit Symbol subtest of the WAIS-R 
(Wechsler, 1981) and the copy portion of the Rey Osterrieth CFT as measures of visual 
perception.  As previously mentioned in the visual memory discussion, the Rey Osterrieth 
CFT is capable of measuring both visual memory and visual perception functioning 
(Corwin & Bylsma, 1993; Osterrieth, 1944).  The copy aspect of the Rey Osterrieth CFT 
is considered to tap into visual perception and motor coordination.  Using the Digit 
Symbol subtest and the copy portion of the Rey Osterrieth CFT, several studies have 
found impairments in visual perception (Carpenter et al., 1993; Judd & Ruff, 1993; 
Swirkey-Sacchetti, 1993). 
 More complex measures that have a strong visual perception component include 
the Embedded Figures Test (Witkin, Oltman, Raskin, & Karp, 1971) and the Corsi 
Blocks, also known as the Block Span test (Milner, 1971).  The Embedded Figures Test 
entails presenting participants with a single geometric design and requiring them to use 
visual discrimination and filtering to identify the shape within a more complex one.  The 
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Corsi Blocks test requires participants to remember and point out increasingly long 
patterns of three-dimensional blocks on a board with forward and backward trials.  In a 
study by O’Leary et al. (1991) performances by BPD participants on both the Corsi 
Blocks Test and the Embedded Figures Test were significantly impaired on all trials.  
Judd and Ruff (1993) delivered the Block Span test and found on the delayed portion of 
the test participants with BPD produced lower mean scores that approached significance 
relative to controls. 
 Other tests have been used by researchers to assess for visual perception deficits 
in persons with BPD and have produced significant findings.  Carpenter et al. (1993) 
found significant impairment in visual perception using Trail-Making Test A and B 
(Reitan, & Davison, 1974; Spreen & Strauss, 1991) and the Block Design subtest of the 
WAIS-R (Wechsler, 1981).  Judd and Ruff (1993) used the Ruff Figural Fluency Test 
(RFFT; Ruff, Light, & Evans, 1987) and found significant deficits in BPD subjects.  All 
of the visual perception tests mentioned include perceiving complex visual arrays that 
require participants to process new information, filter out extraneous stimuli, and select 
relevant visual details from a complex field (O’Leary, 2000). 
 Stevens et al. (2004) examined speed of visual perception via a backward 
masking paradigm.  Participants were presented with a highly visible target (i.e., “A,” 
“T”) for a brief amount of time.  Then, after a variable time interval, a low-contrast mask 
appeared at the same screen location.  Participants were asked to press a button under the 
right index finger when a target was recognized (i.e., “A,” “T”) and press a button under 
the left index finger for non-targets (“X,” “O”).  Results show that BPD subjects required 
significantly more time to recognize the target stimulus compared with controls. 
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Processing Speed 
 Persons with BPD generally display poorer performance on tasks of processing 
speed compared to control groups (Ruocco, 2005).  O’Leary et al. (1991) used the Digit 
Symbol subtest from the WAIS-R (Wechsler, 1981) as a measure of processing speed and 
found significant differences in BPD scores relative to control scores.  These findings of 
processing speed deficits in persons with BPD were replicated by Judd and Ruff (1993) 
using the Digit Symbol subtest and the RFFT (Ruff et al., 1987), which besides being a 
measure of visual perception is also considered a measure of processing speed.  Using a 
German version of the classic Stroop test, Kunert, Druecke, Sass, and Herpertz (2003) 
found differences in speeded processing performance between BPD subjects and controls 
on two subtests.  Dinn and colleagues (2004) found deficits in BPD persons’ processing 
speed performance relative to controls using both trials of the Trail-Making Test A and B 
(Reitan, 1958) as did Travers and King (2005) using only the Trails A portion of the test.  
Lastly, using a backward masking paradigm, Stevens et al. (2004) found significant 
visual perception processing speed deficits in persons with BPD compared with controls. 
 Not all research findings support the idea of processing speed deficits in persons 
with BPD.  Swirsky-Sachhetti et al. (1993) were unable to find significant processing 
speed deficits in persons with BPD using the Stroop Color and Word Test (Golden, 1978) 
and the Trail-Making Test A and B (Reitan, 1958).   
Meta-analysis and Review of Neuropsychological Functioning in Persons with BPD 
 Perhaps the most efficient and pragmatic approach to synthesize and evaluate the 
literature was a meta-analysis of neuropsychological studies involving persons with BPD 
conducted by Ruocco (2005).  An advantage of using a meta-analysis is that it allows for 
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an amalgamation of archival data that provide a more comprehensive analysis of existent 
findings than would be possible in any one study.  Ruocco (2005) chose studies to 
include in his meta-analysis that satisfied certain criteria: reported sufficient data 
allowing for calculation of effect sizes; a clinical sample of BPD persons; 
neuropsychological tests that were standardized, valid and produced reliable scores; BPD 
diagnosis obtained using DSM or ICD-10 classification; and publication in a peer review 
journal.  The meta-analysis categorized each of the neuropsychological tests used in the 
studies into one of six domains: attention, cognitive flexibility, learning and memory, 
planning, speeded processing, and visuospatial skills. 
 Ruocco (2005) expected that amalgamating the individual findings across studies 
would produce a coherent characterization of the neurocognitive features of the disorder.  
The results from the meta-analysis show that significant differences exist between 
persons with BPD and healthy comparison controls in several areas of 
neuropsychological functioning.  Specifically, individuals with BPD performed more 
poorly than healthy control persons in all areas of functioning assessed with effect sizes 
for these domains ranging from medium to large (Ruocco, 2005). 
 Several interesting interpretations can be made based on the findings from 
Ruocco’s (2005) meta-analysis.  First, the significant effect sizes in the areas of attention, 
cognitive flexibility, and speeded processing are possibly indicative of dysfunction in 
frontal lobe functioning in individuals with BPD (Mitchell, Johnson, Raye, & Greene, 
2004; Monchi, Petrides, Petre, Worsley, & Dagher, 2001; Stuss, Floden, Alexander, 
Levine, & Katz, 2001).  These findings are corroborated by other studies that have found 
evidence of frontal lobe pathology in persons with BPD symptomotology in a sample of 
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normal young adults (Ruocco & Trobbst, 2003) and in a head-injury sample (Ruocco & 
Swirsky-Sachetti, 2005).  Additionally, the large effect size in planning and medium-to-
large effects size for the visuospatial domain also support the idea of dysfunction in 
frontal lobe and potentially parietal lobe (Aleman, et al., 2002; Fincham, Carter, van 
Veen, Stenger, & Anderson, 2002; Jacobs & Anderson, 2002; Newman, Carpenter, 
Varma, & Just, 2003).  Lastly, the effect sizes for learning and memory indicate deficits 
that possibly denote dysfunction in frontotemporal areas (Johnson, Saykin, Flashman, 
McAllister, & Sparling, 2004; Kelley et al., 1998). 
 Results from Ruocco’s (2005) study provide support for the use of the Jacksonian 
model as an etiological explanation for BPD symptomotology (Meares, Stevenson, & 
Gordon, 1999).  The Jacksonian model posits that many of the symptoms associated with 
BPD (e.g., emotional dysregulation, identity disturbance, dissociation) are the result of 
disrupted neural connections between the prefrontal cortex and brain regions responsible 
for higher cognitive functioning.  The model suggests that neurocognitive impairment is 
diffuse and global rather than isolated to localized areas of the brain and proposes that 
BPD is the result of a cascade of neuropsychological impairments.  Ruocco’s (2005) 
findings of neuropsychological dysfunction in numerous domains associated with frontal 
lobe operations are congruent with the Jacksonian model. 
 The evidence of a broad range of neurocognitive dysfunction in persons with BPD 
that is based on averaged scores from numerous neuropsychological measures makes it 
difficult to draw conclusions regarding specific areas of brain pathology (Ruocco, 2005).  
Nonetheless, according to Ruocco (2005) it is valuable to acknowledge the localizing 
abilities of certain neuropsychological tests.  For example, greater deficits in nonverbal 
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abilities were found compared with verbal abilities in the meta-analysis, suggestive of 
frontotemporal dysfunction that is more strongly lateralized to the right hemisphere.  
These findings from Ruocco (2005) are consistent with other studies that have indicated 
specific dysfunction in the right hemisphere of persons with BPD (Dinn et al., 2004; 
Niederhofer, 2004).  To make more conclusions about specific areas of dysfunction, 
additional research is needed that utilizes both neuropsychological tests and 
neuroimaging techniques.  Studies utilizing functional magnetic resonance imaging 
(fMRI) techniques with persons diagnosed with BPD revealed evidence of possible 
deficits in frontal and temporal lobes (Driessen et al., 2004; Tebartz van Elst et al., 2003), 
and deficits in amygdala functioning (Donegan et al., 2003).  Additionally, Ruocco 
(2005) notes that fMRI studies demonstrate the presence of a more diffuse 
characterization of brain dysfunction in persons with BPD. 
 While Ruocco’s (2005) meta-analysis generates a clearer picture of neuro-
psychological dysfunction in persons with BPD, it is important to note that there was 
considerable heterogeneity in the effect sizes for several domains.  Factors that likely 
contributed to the variability in effect sizes include the broad range of tests used across 
studies, the variety of diagnostic systems used to define and assess for BPD pathology 
and differences in subject medication regimens.  External validity of the findings is 
limited due to the fact that most of the amalgamated sample was female and many 
samples included subjects with varied co-occurring Axis I and Axis II diagnosis.  The 
inclusion of BPD subjects with co-occurring psychiatric disorders not only adds to 
heterogeneity of effect sizes but also limits the extent to which findings can be 
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generalized to persons with BPD that have other concurrent Axis I and/or Axis II 
disorders (Ruocco, 2005).   
 The existing evidence that demonstrates performance deficits for individuals with 
BPD in one or more area of cognitive functioning raises interesting questions.  For 
example, how are such persons affected by these cognitive impairments?  How do 
impairments in memory, attention, and processing speed affect persons with BPD in 
classroom settings, in therapy sessions, in social scenes, or during complex interpersonal 
interaction?  Research that attempts to answer these questions is important clinically 
because it provides practitioners with vital information that can be incorporated into 
treatment planning and help inform therapists about particular client needs or necessary 
areas of focus.   
 Ruocco (2005) states that the finding of deficits in attention, memory and learning 
skills in persons with BPD suggests that clinicians be aware that insufficiencies in these 
areas of cognitive functioning may interfere with clients’ ability to communicate 
effectively and engage in therapy.  Interestingly, research by Burgess (1991) involving 
persons with BPD found a significant correlation between suicide and neuro-
psychological deficits but not between suicide and level of depression.  Another 
important clinical consideration is the question of whether it is prudent to prescribe 
medications for persons with BPD that have cognitive side effects, or if it is advisable to 
prescribe medications with side effects that do not interfere as much with cognitive 
functioning.  Ruocco (2005) also advises clinicians be aware of the extent to which 
neuropsychological dysfunction in BPD clients act as risk factors for suicide and/or 
parasuicidal behaviors. 
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Validity and Effort in Assessment Data 
 A critical component to interpreting data from a neuropsychological assessment is 
evaluating the validity of the information provided by the examinee.  Bush et al. (2005) 
note that several factors have the potential to compromise the validity of test data 
including secondary gains, resistance to the assessment and/or examiner, a client’s 
confusion regarding the purpose of the evaluation, or existing client factors that could 
interfere with giving optimal effort on a neuropsychological evaluation (e.g., poor client 
sleep, chronic pain).  Travin and Protter (1984) and Slick, Sherman, and Iverson (1999) 
note that the motivation to provide invalid responses may be due to a number of reasons 
including both conscious and unconscious factors.  While the potential for diminished 
effort on neuropsychological tests is typically highest in forensic settings, invalid 
performance resulting from a client’s conscious or unconscious exaggeration or 
fabrication is also possible in clinical settings (Bush et al., 2005). In addition to the 
factors identified above that have the potential to compromise test data validity, clinical 
factors may also interfere with a person’s ability to successfully participate in 
neuropsychological testing (Bush et al., 2005). 
 To determine whether or not test data are valid requires establishing if the 
examinee gave accurate and comprehensive information regarding his or her symptoms 
and history, and if the examinee provided appropriate effort on the tests (Bush et al., 
2005).  Several terms have been provided by Bush and colleagues (2005) that relate to the 
validity of test information or test data: 1) symptom validity; 2) response bias; 3) effort; 
4) malingering; 5) dissimulation.  The authors define symptom validity as the accuracy or 
honesty of the examinee’s signs, symptoms, or performance on neuropsychological tests, 
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and response bias is an attempt to deceive the examiner by providing inaccurate or 
incomplete responses or effort.  Bush et al. (2005) define effort as the investment to 
perform at capacity levels or to perform well, malingering is the deliberate production of 
false or exaggerated symptoms motivated by external sources, and dissimulation is 
defined as intentionally misrepresenting or falsifying symptoms by over-representing or 
under-representing the true status of symptoms. 
 Historically, the detection of invalid testing data has been informed by qualitative 
analysis of responses offered by the examinee (Tombaugh, 1997).  Under such 
circumstances, assessing for patterns of inconsistencies in responses was the principal 
technique used to identify invalid test data.   However, as noted by Tombaugh (1997) 
qualitative analysis of patterns was not always successful in detecting invalid test data.  
Meehl (1954; 1997) and others (e.g., Dawes, Faust, & Meehl, 1989; Heaton, Smith, 
Lehman, & Vogt, 1978) have argued that clinical judgment without supporting 
psychometric data is largely and oftentimes inaccurate when compared with actuarial 
judgment based on empirical evidence from objective measures.  For this reason, 
researchers and clinicians have proposed that neuropsychologists supplant basic clinical 
judgment with scientific evidence produced by psychometrically sound validity-detection 
techniques. 
 Several standard neuropsychological instruments including the WMS-III 
(Mittenberg, Azrin, Millsaps, & Heilbronner, 1993; Wechsler, 1997b), the Category Test 
(DiCarlo, Gfeller, & Oliveri, 2000), and the WAIS III – Digit Span (Heinly, Greve, Love, 
Brennan, & Bianchini, 2004; Wechsler, 1997a) contain validity markers that may provide 
evidence of invalid performance on select cognitive measures (Greve, Bianchini, 
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Mathias, Houston, & Crouch, 2002).  However, oftentimes these validity indicators fail to 
provide sufficient sensitivity or specificity (Bernard, McGrath, & Houston, 1996; 
DenBoer & Hall, 2004; Greve & Bianchini, 2002; Hiscock, Branham, & Hiscock, 1994; 
Suhr & Boyer, 1999). 
 To correct for the relatively poor ability of standard instruments to accurately 
detect level of effort in testing, several specialized tests of effort have been designed.  
Most tests of effort utilize symptom validity testing which is based on a forced choice 
paradigm (Pankratz & Binder, 1997; Slick, Hopp, Strauss, Hunter, & Pinch, 1994; Slick, 
Hopp, Strauss, & Spellacy, 1996).  Using this type of test format involves presenting a 
subject with an initial stimulus, or target item, followed by asking the subject to select the 
target item when it is paired with a foil.  Due to the fact that subjects have a minimum 
50% chance of correctly guessing the answer with this type of testing paradigm, symptom 
validity tests detect low effort partly by identifying those individuals who respond below 
chance accuracy (Loring, 1995).  Because individuals intending to give poor effort rarely 
perform below chance-level, researchers have established cut off scores for several tests 
of effort that are set above chance level of responding and below scores generated by 
neurological patients (Binder, 1993; Binder & Willis, 1991; Tombaugh, 1997).  
Therefore, when a subject scores lower than an individual with diagnosed brain injury 
would typically score there is a strong possibility that the subject is not giving full effort. 
 Contemporary neuropsychological research has emphasized the effect of 
decreased performance on neuropsychological tests completed by individuals with 
depression, head injury, and chronic pain (Gervais et al., 2001; Green & Iverson, 2001; 
Green, Rohling, Lees-Haley, & Allen, 2001; Rohling, Green, Allen, & Iverson, 2002; 
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Suhr, 2003).  In contrast to the observed decreased performance on neuropsychological 
tests with depressed individuals, research involving clinically depressed individuals’ 
performance on a measure of effort, the Test of Mental Malingering (TOMM; Tombaugh, 
1997), revealed that level of depression does not influence an individual’s performance 
on this test (Ashendorf, Costantinou, & McCaffrey, 2004). 
 Given the recent call to include validity tests in neuropsychological testing, it 
seems worthwhile to explore in more depth the possible relationships between BPD and 
effort.  The lack of research concerning effort with BPD populations stands as a 
noteworthy omission within empirical research in light of recommendations made by 
Bush et al. (2005) and others whom maintain that using measures to establish evidence of 
sufficient effort is a valuable and necessary practice to ensure valid data in  
neuropsychological testing.  Because neuropsychologists are expected to account for the 
validity of test results, the inclusion of symptom validity tests should be considered a 
necessary component in any neuropsychological battery. 
Limitations to the Existing Literature 
 There are several possible reasons for the inconsistent findings in 
neuropsychological literature involving persons with BPD including differences in choice 
of diagnostic assessment techniques, low sensitivity of cognitive measures, inadequate 
sample size, subject heterogeneity, and selection criteria.  Ruocco (2005) identified what 
he believes to be major limitations within the existing research that contribute to the 
inconsistent findings.  The first limitation regards the different ways in which BPD has 
been operationally defined from one study to another study.  Some studies have used 
subjects’ self-report to determine BPD diagnoses, other studies have used semi-structured 
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interviews, and some have used unstructured interviews.  A second limitation concerns 
the broad assortment of neuropsychological measures used from one study to the next.  
The use of a wide range of different neuropsychological tests complicates the ability to 
make clear statements about deficits because of varying degrees of construct validity for 
individual tests.  Ruocco (2005) argues that these sources of variability have muddied the 
waters and made it difficult to form a clear picture of the possible brain pathology that 
may underlie BPD. 
 Ruocco (2005) noted that insufficient sample size is yet another limitation and 
likely partly responsible for the inconsistencies and lack of significant findings observed 
in the literature: 
 In light of the result of the present meta-analysis, the seeming inconsistencies 
 observed across past neuropsychological investigations of BPD appear to be 
 artificial.  Based on the effect sizes obtained across the six neurocognitive 
 domains, it is apparent that most prior investigations lacked sufficient power to 
 detect potential differences between BPD and healthy comparison groups on 
 common neuropsychological tasks (p. 199). 
 Ruocco (2005) adds that the mean sample size of existing studies is less than half 
of what is necessary to detect the effect with sufficient statistical power.  One solution 
offered by Haase and McCaffrey (2004) that is capable of producing more consistent 
findings within and across neuropsychological studies includes aggregating scores from 
several measures that tap into specific neuropsychological constructs and conducting 
between-group analyses using the amalgamated test scores.  Such a method was utilized 
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by Monarch et al. (2004) who found significant dysfunction in their sample of persons 
with BPD in seven out of nine cognitive domains investigated.   
 Monarch et al. (2004) also noted several limitations to existent research that 
preclude a clear neuropsychological characterization of BPD.  The authors stated that 
almost no neuropsychological studies involving persons with BPD assessed attention and 
concentration adequately.  That is, those studies that assessed attention neglected to 
implement a broad range of attention measures and/or utilized attention measures with 
debatable construct validity.  Attention is an important ability to assess because it can 
affect all areas of cognitive functioning.  Failure to include adequate measures of 
attention may limit accurate interpretation of meaningful results and serve as an 
impediment to constructing an accurate neuropsychological profile of BPD. 
 Another limitation identified by Monarch et al. (2004) includes the fact that most 
studies focused on assessing one area of cognitive functioning such as executive 
functioning rather than evaluating multiple cognitive domains.  The authors report that 
those studies that did assess multiple domains used a single test, subtest or item, to 
evaluate an area of cognitive functioning.  The argument against using a single measure 
to assess cognitive functioning in a given area is that it does not produce ample data with 
which to make sound, reliable statements and stands as a marked methodological 
deficiency in the literature.  
The Current Study 
 The current study assessed for the presence of cognitive deficits in persons with 
BPD in the areas of verbal memory, processing speed, and attention.  The study intended 
to improve on methodological shortcomings present in existent neuropsychological 
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literature as identified by Ruocco (2005) and Monarch et al (2004).  The limitation of 
inconsistent operational definition of BPD in the existing research was addressed in this 
study by using the most common screening measure of BPD, the Structured Clinical 
Interview for DSM-IV Personality Disorders (SCID-II, First, Gibbon, Spitzer, Williams, 
& Benjamin, 1997). 
 A second limitation, the use of varied measures to assess cognitive functioning in 
neuropsychological research, presents a challenge for one study to address because 
researchers often choose measures not necessarily based on their psychometric 
properties, but rather because of personal preferences and allegiances to certain tests with 
which they are most familiar and comfortable (Rabin, Barr, & Burton, 2005).  However, 
in an effort to address this limitation, the selection of neuropsychological measures used 
in this study was informed by research regarding their sound psychometric properties 
(e.g., score reliability and construct validity) and effect sizes of measures as reported in 
the meta-analytic review by Ruocco (2005).  Hopefully, future research will include 
similar measures to assist in increasing standardization of neuropsychological assessment 
batteries. 
 A third proposed improvement concerned the limitation of insufficient number of 
tests devoted to assess a single cognitive domain.  To correct for this shortcoming 
participants in this study completed several neuropsychological measures for each 
domain being evaluated and a composite score was calculated for each domain.  
Specifically, the test battery included two measures of verbal memory that yielded five 
scores, three measures of processing speed that yielded six scores, and three measures of 
attention that yielded six scores.  The current study used a method of analyzing data that 
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entailed calculating a composite score by aggregating subtest scores from multiple 
measures within each cognitive domain.  Use of a composite score allowed for between-
group analyses based on amalgamated scores.  The study also evaluated subject 
performance using a general index of neuropsychological functioning that contained 
scores from all three domains assessed.  In this way an overall measure of 
neuropsychological performance for BPD persons and healthy control was obtained and 
analyzed. 
 The inclusion of several measures of attention constituted a fourth methodological 
improvement.  The inadequate assessment of attention that has been noted in the 
literature was addressed by including three measures that assessed this domain.  One last 
methodological flaw of other studies was insufficient sample size.  This issue was 
addressed by conducting a power analysis to determine how many subjects were needed 
to maximize the likelihood of significant findings. 
 It has been well documented that individuals with depression suffer from more 
severe cognitive deficits relative to persons without depression (Gfeller, Chibnall & 
Duckro, 1994; Kizilbash et al., 2002; Kurtz & Morey, 1999) and that depression often co-
occurs with BPD (Comtois et al., 1999; Joyce et al., 2003).  The co-occurring 
presentation of the two disorders makes it difficult to determine which disorder 
contributes more to the cognitive deficits.  The strength of the relationship between 
depression and BPD was investigated as was the influence of co-occurring depression 
and BPD on neuropsychological test performance.  
 A review of the literature reveals that no one has yet looked at the role of effort in 
testing performance with this population.  Therefore, the current investigation included a 
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measure of effort to explore possible relationships between test effort and BPD.  Lastly, 
the study also explored the extent to which a neurological disorder diagnosis in BPD 
persons affects performance on neuropsychological tests. 
Hypotheses 
1.  Individuals with BPD will demonstrate significant deficits on a general index of 
neuropsychological performance relative to control subjects. 
2.  Individuals with BPD will demonstrate significant deficits in attention relative to 
control subjects. 
3.  Individuals with BPD will demonstrate significant deficits in verbal memory relative 
to control subjects. 
4.  Individuals with BPD will demonstrate significant deficits in processing speed relative 
to control subjects. 
5a.  Individuals with BPD will have higher levels of depression relative to control 
       subjects. 
 5b.  Individuals with BPD will have depression scores that correlate significantly with 
        scores on the general index of neuropsychological performance. 
Exploratory Areas 
 In addition to the hypotheses identified above, the current study included two 
exploratory areas: 
A.  One exploratory area for the current study was a measure of effort that filled 
in a gap in the literature by evaluating the relationship of effort in testing to BPD.  Also, 
assessing for level of effort helped determine the validity of test data from this study. 
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B.  A second exploratory area for the current study included evaluating the extent 
to which neurological test performance is affected by the presence of both BPD and a 
neurological disorder diagnosis (e.g., trauma, encephalitis, or epilepsy) compared with 
test performance by individuals diagnosed only with BPD. 
Method 
Participant Recruitment 
 Experimental participants were recruited from mental health centers and private 
practitioners in Missoula, MT and from Montana State Hospital in Warm Springs, MT.  
Experimental participants from Missoula were recruited via referrals from clinicians in 
private practice or working at Western Montana Mental Health Center (WMMHC). 
 Prior to beginning recruitment, the researcher met with directors, clinicians and 
psychiatrists from WMMHC and local clinicians to describe the study and ask for their 
assistance in making appropriate referrals.  Written materials were provided with 
information about the study and who might be eligible (see Appendix A), as well as 
flyers advertising and briefly describing the details of the study with contact information 
for the researcher (see Appendix B).  Clinicians and psychiatrists were asked to provide a 
flyer to those clients with a BPD diagnosis, or BPD features, who may be interested in 
participating in the study.  Mental health professionals were instructed to refer only those 
clients who are aware of their BPD diagnosis, or that they have BPD features and may 
have BPD, to avoid participants inadvertently learning about this diagnosis/symptoms via 
participation in the study.  Prior to running any BPD participants, the researcher gained 
permission from the CPC director, Jen Robohm, Ph.D., to use the clinic facilities to 
administer the assessments. 
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 Experimental participants were also recruited from Montana State Hospital in 
Warm Springs, MT.   The procedure for recruiting participants at this site was based on 
prior research protocols used by a UM clinical psychology graduate student and approved 
by the hospital’s Institutional Review Board (IRB).  Participant recruitment began with 
the researcher meeting with the hospital director, Polly Peterson, Ph.D., to gain 
permission to provide a presentation on the study to the hospital IRB committee.  To 
determine which patients were likely study participants (e.g., met BPD criteria) the 
researcher consulted with the hospital director who reviewed patients’ files.  Patients 
were excluded if their symptoms were not sufficiently stabilized, if they were unable to 
consent to participation, or if they exhibited behavioral problems that would make their 
participation problematic. 
 Those patients that were determined appropriate for the study were approached by 
the hospital director and given a brief explanation of the study and the extent of their 
involvement should they choose to participate (i.e., completing questionnaires and tests 
for approximately 2 hours).  Participants were informed that they would be financially 
compensated for their time and effort.   The director answered the patients’ questions 
about the study and then asked if they would be interested in participating in the study.  
Patients who expressed interest in participating were scheduled for a testing appointment 
with the researcher. 
 Control participants consisted of undergraduate students enrolled in an 
Introduction to Psychology course at UM who received 6 credits towards their 
experimental participation requirement for the course.  All control participants were at 
least 18 years of age.  Control participants signed up to participate in the study by 
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recording their names and contact information on a sign-up sheet posted in the 
psychology department at UM.  The researcher contacted the students, explained to them 
what their participation in the study would entail and answered their questions.  Those 
students that were interested in participating were scheduled for an appointment at the 
neuropsychology research lab on The University of Montana campus to complete the 
assessment.  Because BPD is a diagnosis found predominately in females (about 75%; 
American Psychiatric Association, 2000), and this percentage was reflected in the 
number of females in the clinical sample, control subjects were matched to the clinical 
sample on the dimension of gender. 
 All aspects of participant recruitment and participation complied with all policies 
and procedures as outlined and approved by the IRB committee at The University of 
Montana.  Additionally, participant recruitment and participation at the state hospital 
complied with all policies and procedures as outlined by the hospital’s internal IRB.  All 
experimental participants were informed that they would be paid $10 for their 
participation in the 2-hour study.  Control participants were informed that they would 
receive 6 credits toward their course requirements. 
Informed Consent Form 
 All participants completed an informed consent form that outlined their 
involvement in the study, explained confidentiality and the limits to it, as well as notified 
them of their rights as a research participant.  Because participants were recruited from 
several different sites, three tailored informed consent forms were used (see Appendices 
C, D, and E). Each form included specific information relevant to the recruitment site 
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such as where confidential data would be stored, who would have access to them, and the 
type of compensation offered to the participants (e.g., course credit, monetary). 
Human Subjects Protections 
 The current study recruited participants from mental health clinics in Missoula, 
MT and also from Montana State Hospital.  Patients at the hospital are presumed by the 
hospital physicians to have the ability to consent to treatment unless they demonstrate 
that they cannot do so.  The researcher consulted with the hospital director about new 
admissions and all patients who participated in the current study were determined to have 
the ability to consent to treatment and participation in the research study. 
 Upon determining that a patient was able to consent to research participation and 
met the study criteria, the hospital director briefly explained the research opportunity and 
asked if he or she was interested in participating.  The director then scheduled the patient 
for the next available assessment time with the researcher.  Prior to beginning the 
assessment, the researcher explicitly informed each patient that their participation was 
completely voluntary and they were permitted to stop participating at any time.  Each 
participant was informed that he or she would be compensated $10 for completing the 
study and $2 if he or she did not meet study criteria. The researcher verbally described 
the study in more detail, discussed the consent process, and obtained informed consent 
from the participant. Additionally, a HIPAA-required authorization for Montana State 
Hospital to release protected health information to The University of Montana was signed 
by the participant (See Appendix F).  Copies of these documents were made available to 
the participant.  To protect the participant’s identity and ensure confidentiality, the 
originals of these forms were held in a file cabinet separate from the participant’s raw 
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data.  Only the participant, the researcher and the hospital staff had access to these forms 
which were destroyed one year after the completion of the study.  
 All raw data for this study was identified with a 3-digit participant number. The 
researcher stored all raw data, original informed consents, and the identification key in 
locked file cabinets.  In accordance with HIPAA standards, only non-identifiable raw 
data and electronic data were taken from the hospital campus for data analysis at The 
University of Montana’s Department of Psychology.  All data were reviewed by the 
hospital director before being removed from the hospital campus. The informed consents 
and other data will remain in locked cabinets at the hospital until one year following the 
completion of the study, at which time all confidential study materials were shredded. 
 Data gathered from Missoula participants were stored in locked file cabinets in 
the neuropsychology research lab at The University of Montana’s Department of 
Psychology.  Forms with identifying information (e.g., informed consent forms,) and file 
cabinet key were kept separate from the other data.  After one year of the study’s 
completion the researcher had all raw data destroyed. The researcher maintained each 
participant’s data electronically, identified only with the participant number.  
 Several precautionary measures were taken to properly care for participants that 
express significant distress.  The primary investigator who administered all measures was 
a master’s level clinician with thorough training in working with individuals with BPD 
and in risk assessment and debriefing procedures as well as having training in 
neuropsychological assessment.  All experimental participants were participating in on-
going mental health treatment.  Clinical and control participants underwent a debriefing 
following the study which included inquiring about their level of distress, including 
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thoughts of suicide or harming others, the primary investigator had a standard protocol in 
place that he could follow.  No participants in the current study reported feeling 
distressed as a result of completing the assessment. 
Demographic Questionnaire 
 A demographics questionnaire was used to gather information regarding 
participants’ gender, age, ethnic background, marital status, and level of education.  The 
questionnaire also assessed for any diagnosis of a neurological disorder (e.g., seizure 
disorder) or history of head trauma (see Appendix G). 
Measures 
General WMS-III and WAIS-III Normative Data Information 
 Several subtests from the WMS-III (Wechsler, 1997b) and the WAIS-III 
(Wechsler, 1997a) were used in the current study (i.e., Logical Memory, Digit Symbol, 
Symbol Search, Spatial Span).  The norms for the WMS-III were developed based on 
scores from a sample of 1,250 persons spanning 13 age groups between 16 and 89 years 
old, with 100 people in the first 11 age groups, plus 75 people ages 80-84 and 75 people 
ages 85-89 (Wechsler, 1997b).  The authors indicated that the normative sample 
contained adequate distribution of ethnic variability, with data gathered at 28 different 
U.S. sites.  The authors note that the average subtest internal consistency reliability 
coefficient ranges in the .80s and .90s. 
 A strength of the WAIS-III subtests is their relatively complete and representative 
standardizations with 2,450 participants between the ages of 16 and 89 years of age 
comprising the standardization sample (Wechsler, 1997a).  The normative group was 
divided into 13 age groups and stratified on major demographic variables such as age, 
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sex, education level, and geographic location based on the U.S. census data.  The authors 
stated that extensive testing of the subscales was conducted to establish acceptable score 
reliability and construct validity, but provided no reliability coefficients. 
Attention Tests 
 Spatial Span. 
 The Spatial Span subtest from the WMS-III (Wechsler, 1997b) is considered a 
measure of visuospatial attention (Lezak et al., 2004).  The internal reliability coefficient 
for the Spatial Span subtest has an average of .79.  The Spatial Span subtest consists of 
10 cubes mounted on a board in an irregular arrangement.  The task requires participants 
to first observe the examiner tapping the cubes in prearranged sequences.   The 
participant must then reproduce the tapping pattern in the exact order that the sequence 
was presented.  The subtest contains a series of both forward sequences as well as 
backward sequences of increasing length and complexity.  Scoring involves summing the 
number of sequences correctly reproduced by the participant.  The current study used the 
scores from the forward sequence, backward sequence, and total score of Spatial Span for 
statistical analysis. 
 Seashore Rhythm Test. 
 The Seashore Rhythm Test (SRT; Seashore, Lewis, & Saetveit, 1960) has been 
categorized as a sensitive measure of attention and concentration (Lezak et al., 2004).  
The test requires participants to discriminate between 30 like and unlike pairs of brief 
musical beats.  Scoring for the SRT is completed by summing the number of correct 
responses.  The SRT is part of the Halstead-Reitan Battery that includes a normative 
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sample of 196 individuals with a mean age of 45.3 years (SD=19.0), and containing 
67.9% males (Heaton, Grant, & Mathews, 1991).  Internal reliability coefficients of .77 
using split-half and .78 using odd-even have been reported for the test (Bornstein, 1983).  
The current study used the total correct scores from the SRT for statistical analysis.        
 The Ruff 2 & 7 Selective Attention Test. 
 The Ruff 2 & 7 Selective Attention Test was designed to measure aspects of 
sustained and selective visual attention (Ruff & Allen, 1996).  The test is constructed 
based on the notion that attention consists of two proposed mechanisms: Controlled 
Search and Automatic Detection.  As such, the measure assesses differences between 
automatic (obvious distracters) and controlled (less obvious distracters) visual search.  
The Ruff 2 & 7 test measures selective attention through comparison of response 
accuracy and speed in Automatic Detection versus Controlled Search processing tasks.   
 The normative group for the Ruff 2 & 7 Test contained 360 healthy volunteers 
sampled from California, Michigan, and the Eastern seaboard and roughly represented 
the 1980 U.S. census proportions with regard to race (Ruff & Allen, 1996).  The 
normative sample was stratified according to age (16-24 years, 25-39 years, 40-54 years, 
and 55-70 years) and gender (180 woman and 180 men).  Test-retest reliability for the 
measure has been reported to be in the .84 to .97 range (Ruff & Allen, 1996).   
 The automatic condition consists of lines of randomly mixed capital letters with 
the targets 2 and 7 interspersed.  The controlled condition contains lines of random single 
digits with the targets 2’s and 7’s randomly interspersed.  The test includes 20 randomly 
ordered sets of automatic and controlled conditions.  Each set contains three lines with 20 
randomly ordered characters on each line for a total of 60 characters, 10 of which are 2’s 
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an 7’s.  The time allowed to complete the measure is 5 minutes.  The participant is 
instructed to cross out all the 2’s or 7’s in each line moving from left to right.  Scoring 
involves summing the number of hits (correctly identified 2’s and 7’s), omission errors 
(number of times a 2 or 7 was not marked), and commission errors (number of times a 
distracter is marked as a target).  The number of hits and errors are summed and used to 
calculate an automatic search score and a controlled search score.  The current study used 
the Automatic Detection Accuracy score and the Controlled Search Accuracy score for 
statistical analyses.  The present study’s inclusion of the Ruff 2 & 7 Test as a measure of 
sustained attention was a welcomed addition to the literature concerning attention 
functioning in persons with BPD because other than Lenzenweger et al. (2004), no 
research has measured this aspect of attention. 
Verbal Memory Tests 
 Logical Memory. 
 
 The Logical Memory subtest from the WMS-III is considered a measure of verbal 
memory (Wechsler, 1997b).  The examiner reads two stories (Story A and Story B) and 
instructs the examinee to try to remember as many details about each of the stories.  An 
immediate free recall score is obtained after reading each story once and is added to a 
second free recall score obtained for Story B after the examiner reads that story a second 
time to yield a recall total score (Logical Memory I).  A 30-minute delayed recall score 
(Logical Memory II) is obtained for Stories A and B. 
 The Logical Memory subtest contains a story unit score that is obtained by 
calculating the number of story details included on the scoring protocol for Stories A and 
B that are correctly recalled by the examinee. Each story has 25 details with accurate 
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recall responses awarded a “1” and omitted or incorrect recall responses assigned a “0.”  
This scoring system allows for a maximum possible score of 25 points for each story, or a 
maximum possible first recall score of 50 points for both story A and B.  A second recall 
unit score is also calculated for story B with a maximum possible score of 25 points.  
When the second recall unit score is added to the first recall unit score, the maximum 
total recall score is 75 points for Logical Memory I.  A similar scoring system is used for 
Story A and B at 30-minute delay recall, except that neither story is read again, and only 
one recall unit score is calculated for Story B at delay.  The maximum possible score at 
delayed recall is 50 points for the unit score. 
 Scores for the Logical Memory I (i.e. immediate recall) portion of the WMS-III 
have reported reliability between .81 and .91 across the 13 age groups within the 
normative sample (Wechsler, 1997b).  Logical Memory II (i.e., delayed recall) score 
reliabilities ranged from .71 to .87 in the normative sample (Wechsler, 1997b).  The 
current study used the recall total scores for Logical Memory I and Logical Memory II 
for statistical analysis. 
 California Verbal Learning Test-II. 
 The California Verbal Learning Test-II (CVLT-II; Delis, Kramer, Kaplan, & 
Ober, 2000) is designed to use semantic associations as a strategy of learning words, and 
is therefore a test of verbal learning.  The CVLT-II contains a List A that consists of 16 
words in four categories: vegetables, animals, ways of traveling, and furniture.  The test 
contains a List B, an interference task that also contains 16 names of vegetables, and 
animals along with musical instruments and parts of buildings.  As such, the CVLT-II is a 
measure of the interaction between verbal memory and conceptual ability (Lezak, 2004).  
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The examinee reads each word at a rate of about one word per second and the examinee 
is instructed to try and recall as many words from the list as he or she is able to recall in 
any order.  List A has five trials with the examiner re-reading the list aloud after each of 
the first four trials.  After the fifth trial, List B is read to the examinee and he or she is 
asked to recall as many of the items only from List B that he or she is able to recall.  
Then, two “short-term delay” recall tasks of List A are administered.  The first short-term 
delayed free recall task asks the examinee to name as many words from List A in any 
order.  The second short-term delayed cued recall task asks the examinee to recall as 
many words from List A that fit into each of the four categories, one category at a time.  
Finally, a 20-minute long-term delayed free recall trial, similar to the short-term delay 
free recall, is administered. 
 Scoring the CVLT-II produces scores for total correct, total repetitions, total 
intrusions, short-term delay and long-term delay.  The CVLT-II has a normative sample 
of 1,087 adults across seven age groups ranging from 16 to 89 years old and stratified 
according to the U.S. consensus by age, sex, ethnicity, educational level, and area of the 
country (Lezak, 2004).  The authors of the test reported split-half reliability coefficients 
of .77 to .86 (Delis, Kramer, Fridlund, & Kaplan, 1990).  The current study used total 
correct, short-term delay free recall, and long-term delay free recall scores from the 
CVLT-II for statistical analysis.    
Processing Speed Tests 
 Digit Symbol. 
 The Digit Symbol subtest from the WAIS-III is a measure of processing speed 
(Wechsler, 1997a).  The task consists of a number of rows containing small blank 
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squares, each paired with a randomly assigned number from one to nine.  A key is 
provided above the rows that indicate which number corresponds with each symbol.  The 
examinee is given a practice trial of seven symbols to ensure he or she understands the 
task.  Then, the examinee is asked to fill in as many of the blank squares as possible with 
the symbol that is paired with the number above the blank space during a timed trial of 
120 seconds.  The examinee’s score is the number of squares he or she correctly filled in 
with the symbol.  Test-retest reliability coefficients for the Digit Symbol subtest have 
been reported as high in the .82 to .88 range (Wechsler, 1981).  The current study used 
total correct score from the Digit Symbol for statistical analysis. 
 Symbol Search 
 The Symbol Search subtest from the WAIS-III is also considered a measure of 
processing speed (Wechsler, 1997a) with an average internal consistency coefficient of 
.77.  The test entails showing the examinee a series of lines on which there are two cues 
of nonsense figures followed by a string of other nonsense figures.  The examinee is 
asked to mark “yes” or “no” for each line if either of the cue figures is replicated in the 
subsequent string of nonsense figures.  Following a sample trial and a practice trial, the 
examinee is encouraged to complete as many of the items as he or she can in 120 
seconds.  The score is calculated by summing the number of items the examinee 
completed correctly.  The current study used total correct score from the Symbol Search 
for statistical analysis. 
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  Paced Auditory Serial Addition Test. 
 The Paced Auditory Serial Addition Test (PASAT; Gronwall, 1977; Gronwall & 
Sampson, 1974) has demonstrated high internal consistency with correlations ranging 
between .76 to .95 (Sherman, Strauss, & Spellacy, 1997).  Stuss, Stethem, and Pelchat 
(1988) examined a normative group of 90 participants equally divided among three age 
groups (16-29, 30-49, and 50-69).  The PASAT is capable of detecting deficits in 
processing speed in patients with a wide variety of neuropsychological syndromes 
(Tombaugh, 2006).  The test consists of presenting the examinee with 61 randomized 
numbers that require him or her to sum each number to the one that immediately 
preceded it.  For example, if the numbers follow the order “3, 7, 2, 1, 4,” then the 
examinee’s correct responses, beginning immediately after the second number, would be 
“10, 9, 3, 5.”  There are four trials and with each trial the numbers are presented with 
increasing speed such that numbers in the first trail are presented one every 2.4 seconds, 
every 2 seconds for the second trial, every 1.6 seconds for the third trial, and every 1.2 
seconds for the fourth trial.  The examinee is provided first with a 10-digit practice series 
presented at 2.4 seconds.   Scoring is most commonly reported by calculating the number 
of correct responses for each trial or the mean score for all four trials.  The current study 
used participant scores from the four trials in the statistical analyses.  
Test of Effort 
 The Test of Memory Malingering. 
 The Test of Memory Malingering (TOMM; Tombaugh, 1996; 1997) is the most 
popular symptom validity measures employed by private practitioners as well as by 
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neuropsychologists with expertise in malingering research (Shandera, Hall, DenBoer, & 
Crouse, 2004; Slick, Tan, Strauss, & Hultsch, 2004).  The test includes 50 line-drawings 
of common objects that are presented to the client each for 3 seconds with a 1 second 
inter-stimulus interval.  The TOMM has been shown to demonstrate adequate validity 
when used with various psychiatric populations, including individuals diagnosed with 
moderate to severe depression and anxiety (Ashendorf et al., 2004).  Additionally, the 
TOMM has been shown to be an effective validity measure when used for a wide 
spectrum of neurological populations, including litigating and non-litigating patients with 
traumatic brain injuries (TBI) and patients with dementia, aphasia, psychiatric outpatients 
with depression and anxiety, and individuals experiencing acute pain (Ashendorf et al., 
2004; Etherton, Bianchini, Greve, & Ciota, 2005; Gansler, Tombaugh, Moczynski, & 
Rees, 1995; Rees, Tombaugh, Gansler, & Moczynski, 1998).  The current study used 
total correct scores from the TOMM Trial 2 for statistical analysis. 
Beck Depression Inventory 
 The Beck Depression Inventory, Second Edition (BDI-II; Beck, Steer, & Brown 
1996) is a widely used measure of depressive symptomotology that produces a 
continuous score.  All participants completed the BDI-II and information from it was 
used to assess for differences in the level of depression between groups and to help 
explore possible relationships between level of depression in persons with BPD and 
performance on neuropsychological tests.  
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Structured Clinical Interview for the DSM-IV Personality Disorders 
 The BPD items from the SCID-II (First et al., 1997) was used to determine 
presence of the BPD among participants.  The SCID-II is a semistructured interview that 
parallels the DSM-IV-TR personality disorders (Rogers, 2001).  The measure uses a 3-
point rating system: 1=absent or false, 2=subthreshold, 3=threshold or true.  Each BPD 
diagnostic criterion has about two questions on the SCID-II and it is estimated to take 
approximately 25 minutes to complete.  Rogers (2001) notes that the SCID-II is a 
measure that has shown to produce scores that demonstrate acceptable score reliability 
and validity as a measure of personality disorders.  SCID-II interviews were recorded. 
Procedure 
 The researcher spoke with all potential participants from Missoula and provided 
each with a standardized description of the nature and length of the study.  Potential 
participants had an opportunity to ask the researcher any questions they might have had.  
Those persons interested in participating completed a brief phone screening to gather 
information concerning the participants’ contact information, brief demographic 
information (e.g., age) and whether or not BPD participants were currently involved with 
a mental health professional.  Only participants who were seeing a mental health 
professional were included in the study. 
 All participants were assigned a 3-digit participant number and all identifying 
information was kept separate from other data.  Participant numbers were specially coded 
to denote whether participants were from the state hospital, a community mental health 
center, or the control condition.  Missoula participants with a BPD diagnosis were 
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scheduled for an appointment at the CPC to complete the assessment.  Control 
participants were scheduled for an appointment at the neuropsychology research lab. 
 Upon arriving for their appointment, all Missoula participants completed the 
informed consent form, the demographic questionnaire and were then screened for BPD 
using the BPD items from the SCID-II (First et al., 1997).  The SCID-II was used to 
ensure that experimental participants meet criteria for BPD and to screen out control 
participants who meet BPD criteria.  All clinical referrals satisfied the SCID-II BPD 
criteria.  In two cases, control participants met the BPD criteria and their data were used 
as part of the clinical sample and compensated by providing them with their course 
experimental credits.  Control participant recruitment was stratified based on gender to 
match the experimental group.  
 A standardized order of test administration was used for all participants (see 
Appendix H).  Because the verbal memory measures CVLT-II and Logical Memory 
require a 20 minute delay period between immediate and delay trials, during these 
interval periods participants completed approximately 20 minutes of measures that assess 
processing speed and attention.  It is standard practice in neuropsychological testing to 
have participants complete measures during interval periods that assess different 
cognitive functioning domains than that being assessed by the measure with the delay 
trail as it allows for the most economic use of testing time (Lezak et al., 2004).  
 After administering all the measures, experimental participants were paid and 
control participants were awarded their experimental credits and thanked for their 
participation.  Participants were debriefed by providing them with a copy of the informed 
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consent form and encouraged to contact the researcher or his supervisor at the numbers 
provided on the form should they have any questions following the study. 
 Participants recruited from Montana State Hospital completed the same procedure 
used for the Missoula participants except for the fact that they were contacted at the 
hospital, completed a HIPPA Authorization for Disclosure of Protected Health 
Information form and the assessments was conducted on hospital grounds. 
Statistical Analyses 
 Because the study used multiple comparisons in the analysis, there was the 
potential for an increased risk of a Type I error (rejecting the null when it is true or 
erroneously finding significance when it could have occurred by chance).  To protect 
against the probability of a Type I error, a Bonferroni adjustment was applied by dividing 
the desired alpha level (.05) by the number of t-tests (4) conducted on the dependent 
variables (general neuropsychological functioning, attention, verbal memory, and 
processing speed) to determine that a p-value < .0125 (rounded to .01) would be needed 
to establish significance while maintaining the Type I error rate at .05 for the group of 
t-tests. 
 Using Statistical Package for the Social Sciences (SPSS), a composite score was 
calculated for each domain of functioning (i.e., general neuropsychological functioning, 
attention, verbal memory, and processing speed) and utilized in the statistical analysis to 
compare scores from participants with BPD with scores from control participants.  The 
process of calculating composite scores included first converting participants’ raw scores 
into standardized t-scores.  For some subtest scores the conversion from raw score to t-
score was achieved through the use of normative tables provided by the test developers, 
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while conversion of other raw data required the use of equations for converting raw 
scores to z-scores, and then z-scores to t-scores.  The decision to use t-scores as a 
standard measurement allowed for corrections such as age, gender, and other 
demographic information to be made. 
 Next, a factor analysis, specifically a principle component analysis, was 
conducted using subtest scores from each domain to obtain beta weights.  Although a 
larger sample than that being collected in the current study would be required in a factor 
analysis to identify underlying factor structures of the neuropsychological tests, beta 
weights could be calculated with a factor analysis and used in the composite score 
calculations with the sample size utilized in the current study.  Beta weights were used in 
the calculation of the composite scores to determine how much to weight scores from 
each subtest in each domain.  R squared values were obtained from the factor analysis to 
indicate how much variance was explained in each domain by the subtests.  After 
calculating one composite score for each participant for each domain, hypotheses were 
tested using a series of independent samples t-tests to compare mean scores on each 
domain from the BPD participants with mean scores from the control participants. 
Results 
Participants 
 A sample size of 56 participants was obtained, consisting of 49 women and 7 
men.  The control group consisted of 30 undergraduate students from the University of 
Montana, Missoula, MT.  The clinical group included persons diagnosed with BPD and 
contained 21 inpatient participants recruited from Montana State Hospital in Warm 
Springs, MT, and 5 outpatient participants referred by private practitioners and 
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psychiatrists from Western Montana Mental Health Center, Missoula, MT.  All but one 
clinical participant indicated having at lease one other psychological disorder in addition 
to a BPD diagnosis.  Frequencies of co-occurring diagnoses for the clinical and control 
groups are presented in Table 1. 
Table 1.  Frequency of Diagnoses by Sample 
Frequency of Diagnoses by Sample         
Diagnosis      Clinical Group Control Group  
Major Depressive Disorder            13   1 
Bipolar Disorder (I and II)            13   -- 
Posttraumatic Stress Disorder            10    
Generalized Anxiety Disorder            6    -- 
Attention Deficit/Hyperactivity Disorder           5    -- 
Obsessive Compulsive Disorder            4    -- 
Schizoaffective Disorder             2    -- 
Alcohol Abuse              2    -- 
Polysubstance Abuse              2     
Oppositional Defiant Disorder            2    -- 
Intermittent Explosive Disorder            2    -- 
Dissociative Identity Disorder            2    -- 
Personality Disorder, NOS             2    -- 
Eating Disorder (Bulimia Nervosa/Anorexia Nervosa)      1    1 
Social Anxiety Disorder             1    -- 
Marijuana Abuse              1    -- 
Dysthymic Disorder              1    -- 
Schizophrenia               1      
 Table 2 presents demographic information for the clinical and control groups.  A 
Chi-square test for independence showed no significant gender differences between the 
control group and the clinical group, [χ2 (1, n = 56) = .04, p = .69].  A Chi-square test for 
independence was conducted using education level but results demonstrated that the 
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analysis violated the assumption of minimum cases per cell.  To correct for this problem 
and because education level was ordinal data, a Mann-Whitney U Test was used to assess 
for significant differences between the control group and the clinical group in level of 
education.  Results demonstrated no significant differences in level of education between 
the two groups [Z (1, n = 56) = -.90, p = .93].  A Chi Square test was used to assess for 
significant differences in ethnicity between the control group and the clinical group.  
Because a small number of participants endorsed an ethnicity other than Caucasian, the 
ethnicity variable was dichotomized as “Caucasian” or “other races” to avoid violating 
the Chi Square assumption of minimum cases per cell.  The results showed no significant 
differences in between the two groups [χ2 (1, n = 56) = .17, p = .68].  Group differences 
for age were analyzed using an independent samples t-test.  A significant difference 
between the control and clinical group was found for age [t(54) = -3.95, p < .01]. 
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Table 2. 
Demographic Information for Participants        
Demographics  Control Group  Clinical Group          χ2               Z            t 
        n = 30        n = 26      
Gender               .04           --           -- 
 Men           3            4 
 Women         27          22 
Education                --          -.90          --  
         Some high school       0            6 
         High school degree    20           8 
         Some college             10            9 
         College degree            0            3 
Ethnicity                .17          --           --  
 Caucasian        23           22             
 Native American     4            1 
 Asian                       2            0 
 Hispanic         1            3 
Age                            --            --        -3.95* 
 Mean (SD)       20 (5.63)          27 (7.60)      
Note: *p < .01. 
General Neuropsychological Index 
 The hypothesis that participants with BPD would demonstrate significant deficits 
on a general index of neuropsychological performance relative to control participants was 
analyzed using an independent samples t-test to compare the two group’s general 
neuropsychological functioning composite scores.  Results revealed a significant 
difference in mean composite scores on the dependent variable, general neuro-
psychological functioning, between the control group and the clinical group [t(54) = 
10.99, p < .01, η2= .69].  R squared calculation equaled .488 meaning that 48.8% of the 
variance was explained by the 17 subtests used to assess for general neuropsychological 
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functioning.  This value may be considered adequate (Tabachnick & Fidell, 1996).  Table 
3 presents the means and standard deviations for the control group and clinical group for 
the each of the cognitive variables. 
Table 3. 
Means and Standard Deviations by Group for Cognitive Variables     
Dependent  Control Group  Clinical Group    t        Effect Size 
Variable       n = 30        n = 26                          (η2) 
    Mean (SD)   Mean (SD)      
General Index  57.67 (4.97)  41.15 (6.27)  10.99*  .69 
Attention  55.87 (7.09)  43.22 (8.51)   6.07*  .41 
Verbal Memory 57.19 (4.81)  41.70 (7.72)   8.85*  .59 
Processing Speed 56.76 (6.25)  42.20 (7.52)   7.91*  .54  
Note: * p < .01 
Attention 
 The hypothesis that participants with BPD would demonstrate significant deficits 
in attention relative to control participants was analyzed using an independent samples t-
test to compare attention composite scores from the two groups of participants.  Results 
from the analysis revealed a significant difference in mean composite scores (see Table 
3) on the dependent variable, attention, between the control group and the clinical group 
[t(54) = 6.07, p < .01, η2= .41].  R squared calculation for attention equaled .462, 
meaning that 46.2% of the variance was explained by the six attention subtests used in 
the study.  This value may be considered adequate (Tabachnick & Fidell, 1996).  
Verbal Memory 
 The hypothesis that participants with BPD would demonstrate significant deficits 
in verbal memory relative to control participants was analyzed using an independent 
samples t-test to compare the verbal memory composite scores from the two groups of 
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participants.  Results revealed a significant difference in mean composite scores (see 
Table 3) on the dependent variable, verbal memory, between the control group and the 
clinical group [t(54) = 8.85, p < .01, η2= .59].  R squared calculation for verbal memory 
equaled .792, meaning that 79.2% of the variance was explained by the five verbal 
memory subtests included in the study.  This value may be considered quite good 
(Tabachnick & Fidell, 1996), and lends support for the researcher’s choice of measures as 
valid instruments to assess verbal memory.  
Processing Speed 
 The hypothesis that participants with BPD would demonstrate significant deficits 
in processing speed relative to control participants was analyzed using an independent 
samples t-test to compare the processing speed composite scores from the two groups of 
participants.  Results showed a significant difference in mean composite scores (see 
Table 3) on the dependent variable, processing speed, between the control group and the 
clinical group [t(54) = 7.91, p < .01, η2= .54 ].  R squared calculation for processing 
speed equaled .673, meaning that 67.3% of the variance was explained by the six 
processing speed subtests included in the study.  This value also may be considered quite 
good (Tabachnick & Fidell, 1996). 
Education and Neuropsychological Performance 
 To more thoroughly examine the influence of education on the observed 
differences in neuropsychological scores between the control group and clinical group 
four one-way Analyses of Covariance (ANCOVA) were performed on each of the four 
cognitive dependent variables: general neuropsychological functioning, verbal memory, 
attention, and processing speed.  The independent variable consisted of group (control or 
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clinical) and level of education was used as the covariate in the analyses.  After 
controlling for level of education, results showed there were significant differences 
between the clinical group and control group on the dependent variables of general 
neuropsychological functioning [F(1,53) = 118.49, p <.01, η2= .69], verbal memory 
[F(1,53) = 82.03, p < .01, η2= .61], attention [F(1,53) = 36.43, p <.01, η2= .41], and 
processing speed [F(1,53) = 61.63, p <.01, η2 = .54].  These results indicate that the 
significant differences in general neuropsychological functioning, verbal memory, 
attention, and processing speed between the control group and the clinical group were 
due to group differences (i.e., features associated with BPD) and not due to differences in 
level of education between the two groups. 
Depression and Neuropsychological Performance 
 The hypothesis that participants with BPD would demonstrate significantly higher 
levels of depression relative to control participants was analyzed using an independent 
samples t-test to compare the total scores on the BDI-II from the two groups of 
participants.  Results revealed a significant difference in BDI-II scores between the 
control group (M = 6.00, SD = 4.40), and the clinical group [M = 28.08, SD =10.11;  
t(54) = -10.84, p < .01, η2 = .69].  That is, the clinical group’s mean score on the measure 
of depression was considered “moderate” and was significantly higher than the control 
group’s mean score on the measure of depression that was considered “mild” (Beck et al., 
1996). 
 The hypothesis that individuals with BPD would have depression scores that 
correlated significantly with scores on the general index of neuropsychological 
performance was investigated using Pearson product-moment correlation coefficient.  
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Preliminary analyses were performed to ensure no violation of the assumptions of 
normality, linearity and homoscedasticity existed.  There was a strong, significant 
negative correlation between the two variables [r = -.70, n = 56, p < .01], with higher 
levels of depression associated with lower scores on the general measure of 
neuropsychological functioning. 
 To address concerns regarding the possible contribution of depression in the 
observed differences in cognitive functioning between the two groups, an ANCOVA was 
performed using the independent variable, group, and depression was specified as the 
covariate.  Interestingly, after controlling for depression, results showed a significant 
difference between the clinical group and control group on the dependent variables of 
general neuropsychological functioning [F(1,53) = 35.76, p < .01, η2 = .21], verbal 
memory [F(1,53) = 27.02, p < .01, η2 = .20], attention [F(1,53) = 17.09, p < .01, η2 = .19], 
and processing speed [F(1,53) = 13.27, p < .01, η2= .11].  These results indicate that the 
significant differences in the assessed areas of cognitive functioning between the control 
group and the clinical group were due to group differences (i.e., features associated with 
BPD) and not due to differences in level of depression between the two groups. 
Participant Effort 
 The possible relationship between test effort and BPD was explored by using a 
cut off score of 45 on trial 2 for the TOMM to identify the number of participants that 
provided insufficient effort on the tests.  All control and clinical participants scored above 
a 45 on the TOMM trial 1 and 2, supporting the idea that all subjects provided good effort 
on the neuropsychological tests. 
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Neurological Disorder and Neuropsychological Performance 
 A within group analysis of the clinical sample was conducted using an 
independent samples t-test to explore the extent to which neuropsychological test 
performance was affected by a co-occurring BPD diagnosis and a self-reported 
neurological disorder diagnosis.  General neuropsychological functioning scores of BPD 
participants who endorsed having a diagnosed neurological disease (n = 5) were 
compared with general neuropsychological functioning scores of BPD participants who 
did not endorse having a diagnosed neurological disease (n = 21).  Results revealed a 
significant difference in general neuropsychological functioning between BPD 
participants who reported having a diagnosed neurological disease (M = 34.01, SD = 
3.75) and BPD participants who did not report having a diagnosed neurological disease 
[M = 42.85, SD = 5.53; t(24) = -3.37, p < .01, η2= .32].  The results may be interpreted as 
meaning those clinical participants who endorsed having a neurological disease 
performed worse on the measure of general neuropsychological functioning compared 
with clinical participants who did not endorse having a diagnosed neurological disease.  
However, while the assumption of equal variances was met for this t-test analysis, 
interpretation of this result must be made with caution given the unequal and small 
sample size of clinical participants who had a diagnosed neurological disorder. 
 Additionally, a between group analysis was conducted to evaluate the influence of 
a neurological disorder diagnosis on neuropsychological test performance between the 
control group and the clinical group.  An ANCOVA was performed using the 
independent variable, group, and neurological disorder diagnosis was used as the 
covariate.  After controlling for a diagnosis of a neurological disorder, results revealed a 
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significant difference between the control group and clinical group on the dependent 
variables of general neuropsychological functioning [F(1,53) = 122.17, p < .01, η2 = .60], 
verbal memory [F(1,53) = 77.23, p < .01, η2 = .56], attention [F(1,53) = 33.00, p < .01,   
η
2 = .36], and processing speed [F(1,53) = 64.62, p < .01; η2 = .43].  Therefore, the 
observed differences in neuropsychological functioning between the control and the 
clinical group existed after controlling for diagnosed neurological disorder.  These results 
suggest that the differences in test performance may be due to group differences in terms 
of features associated with BPD and not due to differences in diagnosed neurological 
disorders between the two groups.  Again, caution is necessary in interpreting these 
results because of the unequal and small sample size of clinical participants who had a 
diagnosed neurological disorder that was used as the covariate in the analysis.  
Discussion 
 
General Discussion 
 The results of the study demonstrate that, relative to healthy controls, individuals 
with BPD experience cognitive deficits.  Specifically, participants with BPD obtained 
statistically significantly lower scores compared with control group participants on 
measures of attention, verbal memory, processing speed and a measure of general 
neuropsychological functioning that was an amalgamate score of the three previously 
mentioned domains.  These significant differences between the control group and clinical 
group existed even after controlling for possible confounds such as level of education, 
depression, and presence of a diagnosed neurological disorder. 
 Why might individuals with BPD score significantly lower on neuropsychological 
measures relative to individuals without the diagnosis?  One possible explanation is that 
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individuals with BPD have a neurobiology that is different from other persons, caused by 
prenatal teratogens (Abel, 1981, 1982) or postnatal experiences in the form of abuse and 
trauma (Goldman, D’Angelo, DeMaso, & Mezzacappa, 1992; Guzder et al., 1999; 
Guzder et al., 1996; Yen et al., 2002) that have deleterious effects on neurobiological 
development and functioning.  Neuroimaging research findings of smaller amygdala and 
hippocampi in persons with BPD (Driessen et al., 2004; Gurvits et al., 1996) may provide 
a neurobiological explanation for the deficits in cognitive functioning found in the current 
study. 
 Because the hippocampus is a brain structure associated with memory 
functioning, it seems plausible to hypothesize that small hippocampi observed in persons 
with BPD suggests damage to, or abnormal development of, the hippocampus which 
could impair its functioning and result in verbal memory deficits.  Similarly, reduced 
amygdala volume, a brain structure associated with emotional response, suggests damage 
or abnormal development that might interfere with its healthy functioning and result in 
deficits in verbal memory.  For example, malformations in the amygdala may contribute 
to difficulty regulating stress emotions associated with completing 2 hours of 
neuropsychological testing, and consequently, may interfere with performance.  
Additional research that combines neuroimaging techniques with neuropsychological 
testing is needed to explicate the complex relationship between neurobiological structures 
and cognitive functioning in persons with BPD and to help corroborate these hypotheses. 
 Another possible explanation for the observed deficits in cognitive functioning in 
persons with BPD includes the presence of co-occurring psychological disorders.  The 
most commonly reported co-occurring disorders included major depressive disorder, 
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bipolar I or II disorder, posttraumatic stress disorder (PTSD), generalized anxiety 
disorder (GAD) and attention deficit/hyperactivity disorder (ADHD).  While the study’s 
findings existed even after controlling for level of depression, other disorders not 
controlled for in the study may have contributed to the poor performance by the clinical 
sample on the tests of cognitive functioning.  Given the psychological sequelae 
associated with disorders like PTSD, GAD and ADHD that includes difficulty 
concentrating (APA, 2000), it seems reasonable to assume that the symptoms of these co-
occurring disorders influenced the test performance of participants who suffered from 
them.  Additional neuropsychological research with individuals with BPD that controls 
for co-occurring disorders like PTSD, GAD and ADHD is needed. 
  The study found that participants with BPD had significantly higher levels of 
depression compared with the control group.  The strong, negative correlation that existed 
between depression and general neuropsychological functioning meant that as 
participants’ level of depression increased, their scores on the general neuropsychological 
measure decreased.  It was somewhat surprising to find that the control group scored 
within the mild depression range on the BDI-II.  A possible explanation for this finding 
includes the frequency and degree to which control participants endorsed those BDI-II 
items that assessed for disturbances in sleep patterns, tiredness or fatigue, and loss of 
energy.  While these are symptoms associated with depression, they may also be the 
result of a college student’s busy schedule and not necessarily indicative of depression. 
  A particularly remarkable finding was the significant differences in 
neuropsychological performance between the two groups after controlling for depression.  
This was a surprising finding given the empirical evidence that demonstrates individuals 
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with depression suffer from cognitive impairments (Gfeller, Chibnall & Duckro, 1994, 
Kurtz & Morey, 1999, Renneberg et al., 2005, Sprock et al., 2000).  Nonetheless, the 
significant findings with large effect sizes in the current study indicate that the notable 
differences in test performance between the groups can be explained by the presence of 
the BPD diagnosis, and not due to the differences in levels of depression between the two 
groups.  Such a determination is important because it helps elucidates the complex 
relationship between suppressed neuropsychological test performance and factors such as 
depression and BPD. 
 It may be worthwhile to consider what features associated with BPD might have 
affected test scores.  Perhaps the hallmark features of BPD, such as affective instability, 
impulsivity or dissociation contributed to the cognitive deficits, more so than the effect of 
depressive symptoms.  It seems likely that these BPD symptoms would interfere with 
one’s ability to perform well on tests of memory, attention and speed of processing.  
Clinical participants may have experienced frustration during testing and had difficulty 
regulating their emotions, which may have interfered with their ability to focus, and 
consequently their performance suffered.  Maybe a tendency to respond in an impulsive 
manner led to more incorrect responses and low scores.  Perhaps clinical participants that 
felt stressed during the assessment dissociated as a protective coping mechanism causing 
them to be less present and resulting in poor scores. 
 The study explored how the presence of a neurological disease presenting with a 
BPD diagnosis affected performance on neuropsychological tests.  The study found that 
clinical participants who self-reported having a diagnosed neurological disease performed 
worse on the measure of general neuropsychological functioning compared with clinical 
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participants who had no history of a diagnosed neurological disease.  These findings 
indicate that neurological disease contributes to poor test performance in persons who 
have a BPD diagnosis. 
 The study also found that the presence of a neurological disorder diagnosis did 
not significantly contribute to the observed differences in test performance between the 
control group and clinical group.  Therefore, in the current study, differences in 
neuropsychological test performance between the clinical group and the control group 
seemed to be attributable to presence of BPD and not the presence of a neurological 
disorder.  However, interpretation of this finding is tempered by the limitation of a small 
sample size of participants with a diagnosed neurological disease.  It may be that given a 
larger sample size of participants with diagnosed neurological disorders, results would 
show that neurological disorders contribute significantly to poor neuropsychological test 
performance.  The degree to which neurological disorders contribute to deficits in 
neuropsychological test performance in persons with BPD remains an empirical question 
that may be answered by future research’s replication of the current study using larger 
and equal sample sizes of BPD participants with and without a diagnosed neurological 
disease.  
 An exploratory area in the current study included evaluating the role of effort in 
neuropsychological testing with persons with BPD.  All participants in the study provided 
good effort on the neuropsychological tests as measured by the TOMM.  Clinical 
participants provided adequate effort despite the fact that most suffered from a moderate 
degree of depression, had symptoms associated with co-occurring disorders that may 
have been distracting and often performed poorly on the tests.  These findings suggest 
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that the presence of a BPD diagnosis does not indicate a tendency to provide poor effort 
in testing situations, and that the data collected in the study were valid. 
Implications of the Study Findings 
 Overall, the current findings support a growing body of literature that indicates 
deficits in cognitive functioning exist in persons with BPD (Bazanis et al., 2002; Beblo et 
al., 2005; Carpenter et al., 1993; Dinn, et al., 2004; Judd & Ruff, 1993; Monarch et al., 
2004; O’Leary et al., 1991; Ruocco, 2005; Stevens et al., 2004; Swirsky-Sacchetti et al., 
1993).  The study results are important for several reasons.  It seems likely that deficits in 
cognitive functioning would contribute to difficulties in different areas of life for persons 
with BPD.  Generally speaking, deficits in attention and verbal memory could adversely 
impact interpersonal relationships and compromise one’s ability to regulate emotions, 
both of which are features of BPD.  A decreased ability to process information quickly 
may interfere with work performance or ability to maintain employment.  Additionally, 
cognitive deficits in any of these areas may disrupt and hinder a client’s involvement and 
progress in therapy (Allen, 2002).  More specific implications of neuropsychological 
deficits can be discussed by evaluating each of the cognitive domains. 
 The finding that individuals with BPD experience attention difficulties is 
noteworthy because attention is a cognitive ability that affects other areas of cognitive 
functioning (Monarch et al., 2004).  Clinically, this is vital information for therapists to 
be aware of in terms of interpreting client behavior.  As noted by Monarch et al. (2004), 
inattention, forgetfulness or distracted behavior in session may be due to 
neuropsychological impairments rather than perceiving such behavior as a client’s 
resistance to treatment.  Additionally, because of the ubiquitous nature that attention 
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deficits have on other areas of cognitive functioning, it is important for clinicians to be 
aware of evidence that shows individuals with BPD have attention difficulties because 
such evidence may help explain other cognitive limitations displayed by a client. 
 The finding that persons with BPD experience deficits in attention has several 
other clinical implications.  Difficulty sustaining and focusing attention in therapy 
sessions would likely compromise a client’s ability to fully benefit from the therapeutic 
process.  Allen (2002) notes that flexibility on the part of the clinician is a must when 
working with clients who suffer from neuropsychological impairments.  This includes 
both diffuse deficits like decreased attention and impaired processing speed, and more 
focal deficits such as impaired verbal memory.   
 Developing an awareness that attention difficulties may exist for clients with BPD 
may prompt a therapist to adopt certain therapeutic techniques to accommodate for such 
deficits.  Pragmatically, this may look like the therapist asking for feedback from the 
client during sessions to assess if he or she has lost focus.  To accomplish this, Allen 
(2002) offers several suggestions including having the therapist and client agree on a 
prompt or a cue phrase (e.g., “Let’s stay focused”) to use in session to help provide 
structure and focus and minimize tangential discussions.  Also, a therapist could 
introduce more structure by presenting a limited number of goals to address each session 
and provide the client a written list of the goals to help him or her remain attentive.  By 
presenting information at a slower rate and avoiding lengthy sentences the therapist can 
assist clients with cognitive deficits in successfully tracking a topic discussion and 
decreases their confusion or distraction.  A therapist could pause for a few minutes in 
session to allow the client to mentally review the previous discussion, or the therapist 
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could check for the client’s level of understanding throughout the session to help him or 
her manage the therapeutic information and attend to what is being discussed. 
 Another possible implication of attention deficits includes its impact on clients’ 
interpersonal relationships.  Perhaps because of attention deficits, an individual with BPD 
is unable to be attentive and focused with a friend when he or she needs the person to be 
present.  This may cause frustration for both persons and may serve as an added stressor 
in the relationship leading to its dissolution.  Attentional deficits may make it difficult to 
maintain employment, the consequences of which might include financial hardship, 
homelessness, strained relationships, low self-esteem, and frustration.  All of these 
consequences could become added stressors that exacerbate BPD symptoms. 
 A clinical implication of poor verbal memory in individuals with BPD includes 
difficulty effectively communicating and engaging in psychotherapy, a process reliant on 
a client’s ability to recall information communicated verbally.  Successful psychological 
intervention is dependent upon a client’s verbal memory ability to retain conclusions, 
insights, and the context of the dialogue between client and therapist in a session 
(Bennett, 1989).  An inability to recall skills verbally communicated in therapy that teach, 
for example, how to regulate emotions may cause a client to become emotionally 
dysregulated more frequently or more severely.  Given how common emotion 
dysregulation is in persons with BPD, it is seems important for clinicians to consider how 
emotional regulation is impacted by verbal memory deficits. 
 Therapists working with BPD clients may want to consider providing the client 
with a tape recording of therapy appointments to allow him or her to review the sessions’ 
content between meetings.  Another compensatory measure that therapists may employ 
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includes suggesting to clients that they take notes during therapy to help them remember 
salient points discussed in session.  Lewis and Langer (1994) suggest strategies for 
working with clients who have verbal memory deficits that include the use of symbolism 
and working with the client to create visual images to assist in encoding verbal material.  
The authors suggest that this technique may resemble mnemonic techniques such as the 
therapist assigning each letter of an acronym to a therapy goal or homework assignment.  
Allen (2002) recommends the use of a memory notebook that allows clients to organize 
and recall therapy information by recording important points of sessions, changing 
therapy goals, scheduled appointments, and homework assignments.    
 Verbal memory deficits, similar to attention deficits, may contribute to 
relationship difficulties.  For example, perhaps poor verbal memory may cause a person 
with BPD to forget scheduled meetings with friends, or important issues discussed with a 
friend about their relationship and cause frustration and stress for both persons involved.  
Verbal memory deficits may also make it difficult for persons with BPD to find or keep a 
job. Certainly, unemployment creates stressors that may exacerbate BPD symptoms and 
add to the psychological stress experienced by an individual. 
 The finding that individuals with BPD demonstrate deficits with processing speed 
has clinical relevance.  In an age of managed care when delivery of therapeutic services is 
often constrained by time limitations, the speed with which a client can process 
information is likely to influence how beneficial therapy will be for the client.  One 
example of this is managed care providers often require clinicians to utilize manualized 
treatments with a time-limited format.  Manualized treatments often outline material to be 
presented in each psychotherapy session and require clients to be able to process 
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information in a timely fashion.  If a therapist is required to present information at a 
slower pace in therapy because of a client’s cognitive limitations in areas like processing 
speed, this would impede progress and make it difficult to adhere to the therapy schedule 
associated with a manualized treatment.  Clinically, individuals with BPD that display a 
deficit in processing speed may experience this as a barrier to treatment that compromises 
their ability to benefit from therapy that employs manualized interventions.  
 Similar to attention and verbal memory deficits acting as obstacles to 
employment, poor processing speed may also make it difficult for a person with BPD to 
find work or remain employed.  Certainly unemployment creates a host of problems and 
consequences including those previously discussed.  Both impulsivity and intense anger 
are symptoms of BPD that may be exacerbated by poor processing speed.  Difficulty 
processing information quickly may frustrate individuals with BPD and result in less 
patience when problem solving and create a more impulsive pattern of responding.  In 
addition to poor processing speed possibly contributing to impulsivity, the frustration 
associated with the deficit may lead to more bouts of anger or more intense feelings of 
anger. 
 The relationship between medications and cognitive functioning is complex.  
Research has yet to clearly explain the extent to which the myriad of psychotropic 
medications contribute to deficits in cognitive functioning.  However, findings such as 
those from the current study that indicate cognitive difficulties in persons with BPD 
provide important information for clinicians and physicians to consider when prescribing 
medications that have known cognitive side effects.  Prescribing a medication with side 
effects that are less detrimental to cognitive functioning may be an important 
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consideration for clinicians and physicians when working with this population.  
Additionally, research by Dawson (2004) shows that involving BPD clients more in the 
process of selecting medications to mange their symptoms results in them making better 
choices for themselves, not abusing or misusing pills they have chosen themselves, and 
choosing a far more sensible regimen of medication than has been prescribed for them in 
the past. 
 Another important clinical implication of the study’s general findings regarding 
limitations in cognitive functioning in individuals with BPD concerns the issue of 
suicide.  Persons that suffer from BPD have a high rate of self-harm and suicide 
behaviors (Linehan, 1993), and suicide in persons with BPD has been correlated with 
cognitive functioning and not depression (Burgess, 1991).  Therefore, evidence that 
demonstrates persons with BPD have difficulty with attention, verbal memory and 
processing speed provides clinicians with vital information that can be utilized in 
diagnosis, treatment planning, and suicide prevention.  The study results underscore the 
importance that the practice of using screening measures to detect the presence of other 
pathologies and client limitations should include screening for neuropsychological 
impairments in clients with BPD. 
 A clinical intervention with empirical evidence supporting its efficacy in the 
treatment of BPD is Dialectical Behavior Therapy (DBT; Koons et al., 2001; Linehan, 
Armstong, Suarez, Allmon, & Heard, 1991; Linehan, Heard, & Armstrong, 1993; 
Verheul et al., 2003).  DBT is a manual-based treatment that includes a 
psychoeducational skills training component, incorporates several different modes of 
treatment, and involves repetition of skills-based knowledge (Linehan, 1993).  The 
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treatment seeks to apply a variety of cognitive and behavior therapy strategies to the 
problems faced by individuals with BPD, particularly suicidal behaviors. 
 By nature of its design, DBT may serve nicely as an intervention that 
accommodates for the cognitive limitations of persons with BPD.  For example, DBT’s 
didactic approach involves clear instruction and repetition of information and skills 
practice to enhance skills acquisition.  DBT presents material to clients using audio-video 
skills training tapes, printed handouts on skills practice, and makes use of role-playing as 
a teaching tool.  This model of therapy that incorporates clear instruction, repetition and 
multi-dimensional teaching approaches seems ideal for persons with cognitive difficulties 
in areas such as attention, verbal memory and processing speed.  In light of the current 
findings, it is interesting to speculate that perhaps one reason DBT is effective as a 
treatment is because it includes techniques that are sensitive to issues related to the 
cognitive deficits experienced by individuals with BPD.   
Strengths and Limitations 
 The current study contains a number of strengths including its methodology that 
used several measures to assess for cognitive functioning in three areas.  A benefit of 
using multiple measures to evaluate attention, verbal memory, and processing speed was 
that it provided a more comprehensive battery for assessing each area of functioning than 
would have been afforded by using a single measure for each domain.  Also, by utilizing 
several neuropsychological tests the researcher was able to assess for multiple aspects of 
the same construct (e.g., sustained and controlled attention) and test functioning in each 
domain using different mediums of assessment (e.g., visual test and auditory test 
presentations). 
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 The study’s sample size of 56 participants may also be considered a strength.  
Relative to other studies evaluating the neuropsychological functioning in persons with 
BPD, a clinical sample size of 26 can be considered large.  The use of normative data 
tables to convert raw scores into standardized t-scores allowed the researcher to control 
for the confounding effects of variables like age, gender, and level of education for most 
measures used in the study.  Therefore, the use of standardized scores to compare mean 
performance on the neuropsychological measures represented another strength of the 
study.  While age and was accounted for by the use of normative tables for all measures, 
it is important to note that not all tables for the utilized neuropsychological measures 
provided norms that accounted for the variables of gender and level of education.  This 
issue was addressed by conducting a Chi Square test and a Mann-Whitney U test to 
demonstrate that no significant differences existed in gender or level of education 
between the two groups.  Additionally, the results from an ANCOVA that controlled for 
level of education showed that significant differences between the two groups existed due 
to group differences and not due to an education effect.  The medium to large effect sizes, 
as interpreted using guidelines established by Cohen (1988), that were observed in the 
study indicate the differences in cognitive functioning that existed between the two 
groups were notable differences and strengthen the study’s findings. 
 Another strength of the study included the careful screening of participants to 
ensure that all had met criteria for BPD.  Because all participants completed the SCID-II 
(First et al., 1997) the researcher was confident that all participants in the clinical sample 
were accurately diagnosed.  The use of the SCID-II was consistent with diagnostic 
screenings techniques used by other research studies in this area.  Careful screening of 
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participants for the BPD diagnosis strengthened the internal validity of the current study 
and allows the findings to be applied to other individuals diagnosed with BPD.  While the 
current study did not include participants with only BPD diagnoses, it is rare to find such 
cases, as co-occurring substance use, depression, and other Axis I diagnoses are common 
with this population. 
 Several variables often contribute notably to performance on neuropsychological 
tests.  For example, years of education has been identified as a variable that affects test 
performance on measures used in the current study such as the PASAT (Stuss, Stethem, 
& Poirier, 1987), Logical Memory (Richardson & Marottoli, 1996; Ylikoski et al., 1998), 
and the Corsi Block-Tapping Test which closely resembles the Spatial Span subtest from 
the WAIS-III (Orsini et al., 1986).  The study’s analyses found significant differences in 
cognitive functioning continued to exist after controlling for several possible confounds, 
including education, depression and, with less certainty, a neurological disorder 
diagnosis.  Confounding variables like level of education, depression and neurological 
disorders often affect neuropsychological test performance and limit conclusions 
regarding the affect of the primary variable of interest in a study (i.e., BPD) on cognitive 
functioning.  While the study was unable to control for all confounds, the results from the 
analyses that controlled for those variables discussed above provided support for the 
hypothesis that cognitive deficits in persons with BPD were attributable to the disorder 
and not to certain identified extraneous variables. 
 One limitation of the current study included not controlling for possibly 
confounding variables like medications, co-occurring Axis I diagnoses, and 
hospitalization.  It is important to consider the contribution of secondary consequences of 
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BPD such as medications, co-occurring disorders like substance abuse, or hospitalization 
when interpreting the findings.  For example, all experimental participants were taking 
some type of psychotropic medication to help manage their mental illnesses.  Several 
authors found individuals who are taking antiepileptic medications may score low on the 
Digit Symbol and Symbol Search subtests of the WAIS-III (Aldenkamp et al., 2000; 
Pagliaro & Pagliaro, 1999).  Therefore, interpretation of the findings must take into 
account the possible confounding affect medications may have exerted on participants’ 
performance. 
 Additionally, 11 (42%) of the clinical participants self-reported having a 
substance abuse or dependence diagnosis.  Extensive literature demonstrates a correlation 
between chronic alcohol abuse and cognitive deficits in areas including memory, 
visuospatial and executive functioning (Adams & Victor, 1993; Fals-Stewart, Schafer, 
Lucente, Rustine, & Brown, 1994; Grant et al., 1978; Miller, 1991; Parsons, 1987; Reitan 
& Wolfson, 1993).  Also, sustained use of cocaine has been associated with memory 
deficits (Horner, 1997; Mittenberg & Motta, 1993; O’Malley & Gawin, 1990; Rosselli & 
Ardila, 1996; Van Gorp et al., 1999).  As a result, the current study findings must be 
interpreted within the context of co-occurring substance abuse found in over two-fifths of 
the clinical sample. 
 In addition to substance abuse or substance dependence disorders contributing to 
cognitive difficulties, other disorders can have a similar affect on an individual’s 
neuropsychological performance including anxiety (Gass, 2002; Gass, Ansley, & 
Boyette, 1994; Kizilbash et al., 2002), PTSD, and ADHD.  Given the prevalence of these 
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disorders in the clinical sample, it is important to recognize the possible adverse affect 
this disorder exerted on participant performance.      
 Beyond factors such as medications and co-occurring disorders there are other 
explanations for why an individual may perform poorly on a neuropsychological 
assessment.  For example, 20 (77%) of the clinical participants were recruited and tested 
in a hospital setting, suggesting it may be important to consider the effect of 
hospitalization on neuropsychological functioning.  Participants’ length of stay in the 
hospital may have negatively impacted their neuropsychological functioning.  A review 
of the literature reveals little research investigating the affect of hospitalization on 
neuropsychological performance.  Additional research in this area is needed. 
 Another limitation includes the method used to assess for neurological disease 
and, as mentioned previously, the small sample of participants with a neurological 
disorder diagnosis that restricted interpretation of the results.  Because diagnosed 
neurological disorders were determined based on participants’ self-report, it is difficult to 
assess how accurate the prevalence rates for neurological diseases were in the study’s 
sample.  A more precise method for determining presence of a neurological disorder 
diagnosis might include referencing participants’ medical records to corroborate 
participants’ self-reports. 
 The clinical sample was a primarily female in-patient sample (85%), and thus 
constitutes another limitation.  While prevalence rates for the disorder indicate roughly 
75% of diagnosed persons with BPD are female (APA, 2000), the percentage of females 
in the current study was over-representative of this statistic.  Also, the study attempted to 
recruit as homogeneous a sample of participants as possible.  However, because of the 
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obvious limitations associated with data collection in a rural area, the clinical sample 
consisted of both in-patient and outpatient participants.  Therefore, future research is 
necessary to determine to what extent the current study’s findings have external validity 
and can be generalized to males or to outpatient populations with BPD. 
Future Directions 
 Future research in this area may include assessing for deficits in other areas of 
cognitive functioning not addressed in the current study such as executive functioning, 
visuospatial, planning and motor abilities.  Deficits in these areas would generate other 
implications and concerns that may necessitate additional clinical consideration.  For 
example, cognitive limitations in executive functioning or planning are likely to 
contribute to a client’s difficulty anticipating potential triggers that lead to 
decompensation unless effective therapeutic coping skills are used.  Research 
investigating for the presence of other cognitive deficits in persons with BPD would 
provide clinicians with important information that could be used to better adapt 
therapeutic techniques to accommodate clients’ needs.  Additional research into other 
areas of cognitive functioning of persons with BPD, as well as replication of the current 
findings, will assist in the construction of a valid neuropsychological profile of BPD.   
 The nature of BPD makes it very difficult to gather a sample of participants who 
do not have co-occurring diagnoses, are not taking medications, are not hospitalized, or 
do not have a diagnosed neurological condition.  Nonetheless, the possible confounding 
affects of these factors on cognitive functioning are important considerations to try and 
address through additional empirical research.  Future research may seek to control for 
these possible confounds through recruitment of BPD participants with limited co-
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occurring diagnoses, without a neurological condition and who are not taking 
medications.  Lastly, future studies with individuals with BPD may want to include 
conducting comparison analyses of neuropsychological functioning of an inpatient 
sample, an outpatient sample and a healthy control sample to investigate the possible role 
of hospitalization on cognitive functioning. 
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Appendix A 
 
Participant Recruitment Letter 
Dear Clinician, 
My name is Chris Miller and I am a clinical graduate student at The University of 
Montana conducting my dissertation study.  My research project will look at several areas 
of functioning in persons with borderline personality disorder (BPD).  The study will 
require participants to complete several neuropsychological measures of memory and 
processing speed abilities.  Individuals participating in the study will have their identity 
and personal information kept in strict confidentiality.  Additionally, the study will be 
supervised by Dr. Stuart Hall, associate professor in the psychology department at The 
University of Montana.  The study has been approved by the University’s Institutional 
Review Board and all participants will be treated in accordance with the American 
Psychological Association’s (2002) “Ethical Principles of Psychologists and Code of 
Conduct.”  If you have clients with a diagnosis of BPD that would be interested in 
earning $10 to participate in my 2-hour study, I would be very interested in having you 
refer them to me.  Enclosed is a flyer for the study along with my contact information 
where interested persons may call to schedule an appointment with me.  I appreciate your 
help with this request and I thank you for your time. 
 
Sincerely, 
 
 
 
Chris Miller, M.A. 
Clinical Psychology Center 
The University of Montana 
Missoula, MT  59801 
Ph: (406) 243.2367 
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Appendix B 
 
Study Flyer 
 
Are you interested in earning money to answer 
questions? 
 
You could be involved in a research project at The 
University of Montana that offers you an 
opportunity to earn $10 for completing a few tests 
for about 2 hours. 
 
If you have any questions or think you may be 
interested in participating in this study, call the 
person at the number listed below to set up an 
appointment. 
 
 
 
Chris Miller, M.A. 
Clinical Psychology Center 
The University of Montana 
Missoula, MT  59801 
Ph: (406) 243.2367 
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Appendix C 
 
Informed Consent for Warm Springs Participants 
 
Study Title: Neuropsychological Correlates of Borderline Personality Disorder 
 
 
Investigators: Christopher Miller, M.A.   Stuart Hall, Ph.D. 
  Department of Psychology   Department of Psychology 
  University of Montana   University of Montana  
  Missoula, MT  59812    Missoula, MT  59812 
  (406) 243.4522    (406) 243.5667 
 
 
     Polly Peterson, Ph.D. 
     Department of Psychology 
     Montana State Hospital 
     PO Box 300  
     Warm Springs, MT  59706 
     (406) 693-7120 
 
Please Note 
 This consent form may contain words that are new to you.  If you read any words 
that are not clear to you, please ask the person who gave you this form to explain them to 
you. 
 
Purpose 
 The purpose of this study is to determine how well individuals with borderline 
personality disorder (BPD) perform on a number of different measures that assess 
different areas of functioning like memory and attention skills relative to individuals 
without the diagnosis.  We are interested in studying how individuals do on these 
measures because we believe it will provide valuable information that can be used to 
improve treatment programs that will better serve clients’ needs. 
 
Procedure 
 If you agree to take part in this research, and complete all the measures, it will 
involve approximately 2 hours of your time.  You will be asked to complete a form that 
asks about your background information (e.g., date of birth, level of education).  An 
interviewer will ask you about your current emotional problems and your past and 
present psychiatric history, including questions about depression, trauma history, and 
drug and alcohol use.  You will be asked about your mood, thinking, impulsive behavior 
and interpersonal relationships.  This portion of the study will be recorded, but no 
identifying information will be included on the audiotape.  Because we are looking for 
participants with some specific characteristics, you may or may not have the 
characteristics we need for this study.  If you do not, you will be told so immediately and 
you will be paid $5 for your time and you will be finished with the study.  If you do have 
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the characteristics needed for the study, you will be told so immediately.  If you decide to 
continue with the study, you will be asked to complete a series of tests that will assess 
your attention, memory and ability to work quickly.  If you complete the study you will 
be paid $15 for your effort and time. 
 
Risks/Discomforts 
 There are no serious risks or discomforts associated with this study.  However, 
answering some of the questions may cause you to sad or upset.  If this happens, you can 
choose not to answer certain questions, or choose not to complete the study. The research 
assistant will be happy to talk to you about these problems things if they occur.   
 
Benefits of the Research 
 The study is not specifically designed to benefit you directly.  The primary benefit 
will be to add to our knowledge base about what types of difficulties in functioning 
persons with BPD have relative to individuals without the diagnosis.  The information 
gathered from this study will increase clinicians’ awareness of deficits with this 
population and improve the effectiveness of treatment. 
 
Confidentiality 
 You will be assigned a study number, and that number will be used by the 
researchers to track your data.  Information you provide will not leave the hospital with 
your name attached to it; instead, you will be called (for example) “participant 000” for 
the purposes of analyzing the research data.  The people who work at Montana State 
Hospital will not have direct access to the answers you give on the tests or to your 
demographic information.  Forms with your name on it (i.e., Informed Consent, HIPPA 
Authorization for Disclosure of Protected Health Information, Competency Assessment) 
will be kept separate from your test answers so as not to be identified with you.  All data 
will be stored in locked filed cabinets and accessed only by the study investigators.  
Finally, if you report that you feel suicidal, feel like harming yourself, or feel like 
harming someone else, or if you behave as if you are going to do any of those things, the 
researcher will disclose that information to the hospital staff because of concerns about 
your safety. 
 
Compensation for Injury 
   Although we do not foresee any risk in taking part in this study, the following 
liability statement is required in all University of Montana consent forms:  
 In the event that you are injured as a result of this research, you should 
 individually seek appropriate medical treatment.  If the injury is caused by the 
 negligence of the University  or any of its employees, you may be entitled to 
 reimbursement or compensation pursuant to the Comprehensive State Insurance 
 Plan established by the Department of Administration under the authority of 
 M.C.A., Title 2, Chapter 9.  In the event of  a claim for such injury, further 
 information may be obtained from the University’s  Claims Representative or 
 University Legal Counsel.  (Reviewed by University Legal Counsel, July 6, 
 1993). 
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Voluntary Participation/Withdrawal:  Your decision to take part in this research study is 
entirely voluntary. You may refuse to take part, or you may choose to withdraw from the 
study at any time without penalty or loss of benefits that you normally receive at 
Montana State Hospital. Also, you may be asked to leave the study if the Project Director 
or your treatment providers think it that participation is not in your best interest.  Should 
you choose or be asked to withdraw from the study, the researcher will be available to 
you following your withdrawal if you would like to discuss your experience with the 
study. Again, your decision to participate or not participate in this research will in no way 
affect your treatment at Montana State Hospital.  
 
Questions 
 If you have any questions about the research or the results of the study, either 
now, during or after the study, you may contact Christopher Miller (406.243.4522) or Dr. 
Stuart Hall (406.243.5667).  If you have any questions regarding your rights as a research 
participant, you may contact the Research Offices at The University of Montana at (406) 
243.6670. 
 
Participant Statement of Consent 
 I have read the above description of this research study.  I have been informed of 
the risks and benefits involved, and all of my questions have been answered to my 
satisfaction.  Furthermore, I have been assured that any future questions I may have will 
also be answered by a member of the research team.  I voluntarily agree to take part in 
this study and consent to be contacted in the future by the researchers to ask if I would be 
interested in participating in additional studies.  I understand I will receive a copy of this 
consent form. 
 
 
 
 
Printed Name of Participant    Date  Participant ID number 
 
 
 
 
Participant’s Signature    Date 
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Appendix D 
 
Informed Consent Form for Missoula Clinical Participants 
Study Title: Neuropsychological Correlates of Borderline Personality Disorder 
 
Investigators: Christopher Miller, M.A.   Stuart Hall, Ph.D. 
  Department of Psychology   Department of Psychology 
  University of Montana   University of Montana  
  Missoula, MT  59812    Missoula, MT  59812 
  (406) 243.4522    (406) 243.5667 
 
Please Note 
 This consent form may contain words that are new to you.  If you read any words 
that are not clear to you, please ask the person who gave you this form to explain them to 
you. 
 
Purpose 
 The purpose of this study is to determine how well individuals with borderline 
personality disorder (BPD) perform on a number of different measures that assess 
different areas of functioning like memory and attention skills relative to individuals 
without the disorder.  We are interested in studying how individuals do on these measures 
because we believe it will provide valuable information that can be used to improve 
treatment programs that will better serve clients’ needs. 
 
Procedure 
 If you agree to take part in this research, and complete all the measures, it will 
involve approximately 2 hours of your time.  You will be asked to complete a form that 
asks about your background information (e.g., date of birth, level of education).  An 
interviewer will ask you about your current emotional problems and your past and 
present psychiatric history, including questions about depression, trauma history, and 
drug and alcohol use.  You will be asked about your mood, thinking, impulsive behavior 
and interpersonal relationships.  This portion of the study will be recorded, but no 
identifying information will be included on the audiotape.  Because we are looking for 
participants with some specific characteristics, you may or may not have the 
characteristics we need for this study.  If you do not, you will be told so immediately and 
you will be paid $5 for your time and you will be finished with the study.  If you do have 
the characteristics needed for the study, you will be told that immediately.  If you decide 
to continue with the study, you will be asked to complete a series of tests that will assess 
your attention, memory and ability to work quickly.  If you complete the study you will 
be paid $15 for your effort and time. 
 
Risks/Discomforts 
 There are no serious risks or discomforts associated with this study.  However, 
answering some of the questions may cause you to sad or upset. If this happens, you can 
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choose not to answer certain questions, or choose not to complete the study. The research 
assistant will be happy to talk to you about these problems things if they occur.   
 
Benefits of the Research 
 The study is not specifically designed to benefit you directly.  The primary benefit 
will be to add to our knowledge base about what types of difficulties in functioning 
persons with BPD have relative to individuals without the disorder.  The information 
gathered from this study will increase clinicians’ awareness of deficits with this 
population and improve the effectiveness of treatment. 
 
Confidentiality 
 You will be assigned a study number, and that number will be used by the 
researchers to track your data.  Information you provide will not have your name attached 
to it; instead, you will be called (for example) “participant 000” for the purposes of 
analyzing the research data.  Your informed consent form with your name on it will be 
kept separate from your test answers so as not to be identified with you.  All data will be 
stored in locked filed cabinets and accessed only by the study investigators.  If you report 
that you feel suicidal, feel like harming yourself, or feel like harming someone else, or if 
you behave as if you are going to do any of those things, the researcher will take the 
necessary steps to ensure your safety including consulting with a clinical supervisor.  
 
Compensation for Injury 
 Although we do not foresee any risk in taking part in this study, the following 
liability statement is required in all University of Montana consent forms:  
 In the event that you are injured as a result of this research, you should 
 individually seek appropriate medical treatment.  If the injury is caused by the 
 negligence of the University  or any of its employees, you may be entitled to 
 reimbursement or compensation pursuant to the Comprehensive State Insurance 
 Plan established by the Department of Administration under the authority of 
 M.C.A., Title 2, Chapter 9.  In the event of  a claim for such injury, further 
 information may be obtained from the University’s  Claims Representative or 
 University Legal Counsel.  (Reviewed by University Legal Counsel, July 6, 
 1993). 
 
Voluntary Participation/Withdrawal 
 Your decision to take part in this research study is entirely voluntary. You may 
refuse to take part, or you may choose to withdraw from the study at any time without 
penalty.  Should you choose or be asked to withdraw from the study, the researcher will 
be available to you following your withdrawal if you would like to discuss your 
experience with the study. 
 
Questions 
 If you have any questions about the research or the results of the study, either 
now, during or after the study, you may contact Christopher Miller (406.243.4522) or Dr. 
Stuart Hall (406.243.5667).  If you have any questions regarding your rights as a research 
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participant, you may contact the Research Offices at The University of Montana at (406) 
243.6670. 
 
Participant Statement of Consent 
 I have read the above description of this research study.  I have been informed of 
the risks and benefits involved, and all of my questions have been answered to my 
satisfaction.  Furthermore, I have been assured that any future questions I may have will 
also be answered by a member of the research team.  I voluntarily agree to take part in 
this study and consent to be contacted in the future by the researchers to ask if I would be 
interested in participating in additional studies.  I understand I will receive a copy of this 
consent form. 
 
 
 
 
Printed Name of Participant    Date  Participant ID number 
 
 
 
 
Participant’s Signature    Date 
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Appendix E 
 
Informed Consent Form for Control Participants 
Study Title: Neuropsychological Correlates of Borderline Personality Disorder 
 
Investigators: Christopher Miller, M.A.   Stuart Hall, Ph.D. 
  Department of Psychology   Department of Psychology 
  University of Montana   University of Montana  
  Missoula, MT  59812    Missoula, MT  59812 
  (406) 243.4522    (406) 243.5667 
 
Please Note 
 This consent form may contain words that are new to you.  If you read any words 
that are not clear to you, please ask the person who gave you this form to explain them to 
you. 
 
Purpose 
 The purpose of this study is to determine how well individuals with borderline 
personality disorder (BPD) perform on a number of different measures that assess 
different areas of functioning like memory and attention skills.  We are interested in 
studying how individuals do on these measures because we believe it will provide 
valuable information that can be used to improve treatment programs that will better 
serve clients’ needs. 
 
Procedure 
 If you agree to take part in this research, and complete all the measures, it will 
involve approximately 2 hours of your time.  You will be asked to complete a form that 
asks about your background information (e.g., date of birth, level of education).  An 
interviewer will ask you about your current emotional problems and your past and 
present psychiatric history, including questions about depression, trauma history, and 
drug and alcohol use.  You will be asked about your mood, thinking, impulsive behavior 
and interpersonal relationships.  This portion of the study will be recorded, but no 
identifying information will be included on the audiotape.  Because we are looking for 
participants with some specific characteristics, you may or may not have the 
characteristics we need for this study.  If you do not, you will be allowed to continue with 
the study if you choose to do so.  If you decide to continue with the study, you will be 
asked to complete a series of tests that will assess your attention, memory and ability to 
work quickly.  If you complete the study you will receive your 6 experimental credits. 
 
Risks/Discomforts 
 There are no serious risks or discomforts associated with this study.  However, 
answering some of the questions may cause you to sad or upset. If this happens, you can 
choose not to answer certain questions, or choose not to complete the study. The research 
assistant will be happy to talk to you about these problems things if they occur.   
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Benefits of the Research 
 The study is not specifically designed to benefit you directly.  The primary benefit 
will be to add to our knowledge base about what types of difficulties in functioning 
persons with BPD have relative to individuals without the diagnosis.  The information 
gathered from this study will increase clinicians’ awareness of deficits with this 
population and improve the effectiveness of treatment. 
 
Confidentiality 
 You will be assigned a study number, and that number will be used by the 
researchers to track your data.  Information you provide will not have your name attached 
to it; instead, you will be called (for example) “participant 000” for the purposes of 
analyzing the research data.  Your informed consent form with your name on it will be 
kept separate from your test answers so as not to be identified with you.  All data will be 
stored in locked filed cabinets and accessed only by the study investigators.  If you report 
that you feel suicidal, feel like harming yourself, or feel like harming someone else, or if 
you behave as if you are going to do any of those things, the researcher will take the 
necessary steps to ensure your safety including consulting with a clinical supervisor. 
 
Compensation for Injury:  Although we do not foresee any risk in taking part in this 
study, the following liability statement is required in all University of Montana consent 
forms:  
 In the event that you are injured as a result of this research, you should 
 individually seek appropriate medical treatment.  If the injury is caused by the 
 negligence of the University  or any of its employees, you may be entitled to 
 reimbursement or compensation pursuant to the Comprehensive State Insurance 
 Plan established by the Department of Administration under the authority of 
 M.C.A., Title 2, Chapter 9.  In the event of  a claim for such injury, further 
 information may be obtained from the University’s  Claims Representative or 
 University Legal Counsel.  (Reviewed by University Legal Counsel, July 6, 
 1993). 
 
Voluntary Participation/Withdrawal:  Your decision to take part in this research study is 
entirely voluntary. You may refuse to take part, or you may choose to withdraw from the 
study at any time without penalty.  Should you choose or be asked to withdraw from the 
study, the researcher will be available to you following your withdrawal if you would like 
to discuss your experience with the study. 
 
Questions 
 If you have any questions about the research or the results of the study, either 
now, during or after the study, you may contact Christopher Miller (406.243.4522) or Dr. 
Stuart Hall (406.243.5667).  If you have any questions regarding your rights as a research 
participant, you may contact the Research Offices at The University of Montana at (406) 
243.6670. 
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Participant Statement of Consent 
 I have read the above description of this research study.  I have been informed of 
the risks and benefits involved, and all of my questions have been answered to my 
satisfaction.  Furthermore, I have been assured that any future questions I may have will 
also be answered by a member of the research team.  I voluntarily agree to take part in 
this study and consent to be contacted in the future by the researchers to ask if I would be 
interested in participating in additional studies.  I understand I will receive a copy of this 
consent form. 
 
 
 
 
Printed Name of Participant    Date  Participant ID number 
 
 
 
 
Participant’s Signature    Date 
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Appendix F 
 
HIPPA AUTHORIZATION FOR DISCLOSURE OF PROTECTED HEALTH INFORMATION 
THE UNIVERSITY OF MONTANA 
A HYBRID ENTITY AS DEFINED BY HIPAA 
 
AUTHORIZATION FOR DISCLOSURE OF PROTECTED HEALTH INFORMATION TO The 
University of Montana, Missoula, Department of Psychology BY ANOTHER ENTITY 
 
At the request of The University of Montana, Missoula, Department of Psychology, I authorize Montana 
State Hospital to disclose to The University of Montana, Missoula, Department of Psychology the 
following (hereinafter a protected health information): 
 
 Diagnostic information 
 Medication information 
 Assessment information 
 
This protected health information is to be used by The University of Montana, Missoula, Department of 
Psychology only for the following purpose: 
 
To carry out research in an effort to better characterize and define a specific neurological profile of 
borderline personality disorder. 
 
I acknowledge that I understand that treatment, payment, enrollment in a health plan, or eligibility for 
benefits is not dependent on my signing of this Authorization.  However, the University of Montana, 
Missoula, Department of Psychology may require my signing of this authorization before I may participate 
in this study.   
 
I may refuse to sign this authorization if I choose. 
 
Requestor may use or disclose existing protected health information (PHI) or PHI created within the next 
six (6) months for up to thirty (30) months from the date of my signing this authorization. 
 
At all times, I retain the right to revoke this Authorization, except if the Authorization was obtained as a 
condition of obtaining insurance coverage.  Such revocation must be submitted to The University of 
Montana, Missoula, Department of Psychology, in writing.  The revocation shall be effective except to the 
extent that The University of Montana, Missoula, Department of Psychology, has already used or disclosed 
information in reliance on the Authorization.  I may revoke this authorization by sending written notice to: 
 
 Chris Miller, M.A., Department of Psychology, The University of Montana, Missoula, MT, 59812 
 
I have been informed and understand that information used or disclosed pursuant to this Authorization may 
be subject to redisclosure by recipient of such information, and at that point, the information may no longer 
be protected under the terms of this Authorization.   
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I HAVE READ AND UNDERSTAND THIS INFORMATION.  I HAVE RECEIVED A COPY OF 
THE FORM AND I AM THE PATIENT OR AM AUTHORIZED TO ACT ON BEHALF OF THE 
PATIENT TO SIGN THIS DOCUMENT VERIFYING AUTHORIZATION FOR THE USE OR 
DISCLOSURE OF THE PROTECTED HEALTH INFORMATION UNDER THE ABOVE 
STATED TERMS. 
 
________________________________________  _________________ 
Signature       Date 
 
________________________________________ 
Printed Name 
 
________________________________________  _________________ 
Signature of Witness      Date 
 
 
Certain portions of this document were reproduced, with permission, from a document copyrighted by 
HIPAA COW 2002. 
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Appendix G 
 
DEMOGRAPHICS FORM 
Participant ID Number__ __ __ 
 
1. What is your age?    ____ Years old 
 
2.    What is your gender? (check one)   _____ Female 
       _____ Male 
       _____ Transgender 
 
3.   What is your race or ethnic background?  _____ African American 
 (check all that apply)    _____ White/Caucasian  
       _____ Asian American 
       _____ Native American 
       _____ Hispanic 
       _____ Alaska Native/Pacific Islander 
       _____ Other (specify): ___________ 
 
4.   What is your marital status?   _____ Single 
(check all that apply)    _____ Living together 
_____ Married 
       _____ Divorced 
       _____ Separated   
       _____ Widowed 
 
5. What is your highest level of education?  _____ Eight grade or less 
       _____ Some high school 
       _____ High school graduate (GED) 
_____ Some college 
_____ College graduate 
_____ Master’s degree 
_____ Doctoral degree 
 
Yes No 
 
6. Are you currently in therapy?      ____     ____     
 If yes, with whom? _______________________________ 
 What is his/her phone number?  __________________________ 
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          Yes  No 
7. Are you currently seeing a psychiatrist?     ____     ____ 
 If yes, who? _______________________________ 
 What is his/her phone number?  __________________________ 
 
8. Are you currently seeing a case manager?     ____     ____ 
 If yes, who? _______________________________ 
 What is his/her phone number?  __________________________ 
 
9. Do you experience any problems with your hearing?    ____     ____  
 
10. Are you applying for social security disability income?   ____     ____ 
 
11. Are you involved with any legal proceedings?    ____     ____ 
 
12.  Have you ever been diagnosed with any neurological condition?  ____     ____ 
      (e.g., seizure disorder, encephalitis), or have you ever had a blow to 
 your head in which you were unconscious for longer than 30 minutes? 
 If so, please describe briefly: ___________________________ 
 ___________________________________________________ 
 
13.   Have you ever been diagnosed with a learning disability   ____ ____ 
and/or attention deficit disorder with or without hyperactivity? 
If so, please describe briefly: ___________________________ 
___________________________________________________ 
        
14. Have you ever been formally diagnosed with borderline personality  ____     ____ 
 disorder or told that you have characteristics of BPD? 
 
15.  Do you have a current substance abuse or dependence diagnosis?  ____ ____ 
 
16. Please list all medications you are currently taking. 
 Drug Taken  Amount Taken  Time Taken 
 _______________ _______________ __________ 
 _______________ _______________ __________ 
 _______________ _______________ __________ 
 _______________ _______________ __________ 
 _______________ _______________ __________ 
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17.  Please list all current mental disorder diagnoses.  1._________________________ 
        2._________________________ 
        3._________________________ 
        4._________________________ 
        5._________________________ 
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Appendix H 
 
Order of Test Administration  
Informed Consent Form 
HIPPA Authorization for Disclosure of Protected Health Information Form (Warm Springs 
Demographic Information Form           Participants 
only) 
Beck Depression Inventory-II 
Structured Clinical Interview for the DSM-IV Personality Disorders - BPD items 
 
California Verbal Learning Test, List A, immediate free recall trials 1-5 
California Verbal Learning Test, List B, immediate free recall 
California Verbal Learning Test, List A, short-delay free recall 
California Verbal Learning Test, List A, short -delay cued recall 
 
Test of Mental Malingering, Trial 1 
Test of Mental Malingering, Trial 2 
 
California Verbal Learning Test, List A, long-delay free recall 
California Verbal Learning Test, List A, long-delay cued recall 
California Verbal Learning Test, List A, long-delay Yes/No recognition 
 
Wechsler Memory Scale-III - Logical Memory I 
 
Ruff 2 & 7 Selective Attention Test 
 
Seashore Rhythm Test 
 
Wechsler Memory Scale-III - Logical Memory II 
 
Wechsler Memory Scale-III - Spatial Span 
 
Wechsler Adult Intelligent Scale-III - Digit Symbol 
 
Wechsler Adult Intelligent Scale-III - Symbol Search 
 
Paced Auditory Serial Test 
 
